An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (EBS)
Phase: PHASE2
Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Simplex
Sponsor: Castle Creek Pharmaceuticals, LLC

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



&/,1,&$/678'<35272&2/

',$&(5(,12,170(17
*/2%$/35272&2/180%(5&&3
35272&2/$0(1'0(17


3URWRFRO7LWOH
$Q,QWHUQDWLRQDO0XOWLFHQWHU2SHQODEHO/RQJ7HUP([WHQVLRQ6WXG\(YDOXDWLQJWKH6DIHW\RI
'LDFHUHLQ2LQWPHQW7RSLFDO)RUPXODWLRQLQ6XEMHFWVZLWK(SLGHUPRO\VLV%XOORVD6LPSOH[
(%6
,1'1XPEHU

(XGUD&71XPEHU

,QGLFDWLRQ6WXGLHG
(SLGHUPRO\VLV%XOORVD6LPSOH[
3URWRFRO'DWH
0$<
6SRQVRU$GGUHVV
&DVWOH&UHHN3KDUPDFHXWLFDOV//&
&HQWXU\'ULYH6XLWH
3DUVLSSDQ\1-
8QLWHG6WDWHVRI$PHULFD




&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWLVFRQILGHQWLDODQGLVDSULYLOHJHGFRUUHVSRQGHQFHRI&DVWOH&UHHN3KDUPDFHXWLFDOV//&
$FFHSWLQJWKLVGRFXPHQWFRQVWLWXWHVDQDJUHHPHQWE\WKHUHFLSLHQWWKDWQRXQSXEOLVKHGLQIRUPDWLRQKHUHLQ
FRQWDLQHGZLOOEHXVHGGLVFORVHGRUSXEOLVKHGZLWKRXW&DVWOH&UHHN3KDUPDFHXWLFDOV¶SULRUZULWWHQ
DSSURYDO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020
NCT03389308

Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



,19(67,*$7256321625$*5((0(17
,KDYHUHFHLYHGDQGUHDGWKH,QYHVWLJDWRU¶V%URFKXUHIRUWRSLFDO'LDFHUHLQ2LQWPHQW
&&3,KDYHUHDGWKH&&3SURWRFRODPHQGPHQWDQGDJUHHWRFRQGXFWWKHVWXG\
DVRXWOLQHGLQWKLVSURWRFRODQGUHOHYDQWUHYLVLRQV,DJUHHWRPDLQWDLQWKHFRQILGHQWLDOLW\RIDOO
LQIRUPDWLRQUHFHLYHGRUGHYHORSHGLQFRQQHFWLRQZLWKWKLVSURWRFRO








3ULQWHG1DPHRI,QYHVWLJDWRU








6LJQDWXUHRI,QYHVWLJDWRU





'DWH




















Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6321625¶6&217$&7,1)250$7,21


5ROHLQ6WXG\
1DPH
$GGUHVVDQG7HOHSKRQH
1XPEHU
&OLQLFDO2SHUDWLRQV/HDGHU6SRQVRU
&OLQLFDO2SHUDWLRQV/HDGHU6SRQVRU
5HVSRQVLEOH3K\VLFLDQ6SRQVRU
*OREDO&OLQLFDO3URMHFW0DQDJHU

0HGLFDO0RQLWRU


Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7$%/(2)&217(176
5(35(6(17$7,9(6)520&$67/(&5((.3+$50$&(87,&$/6&2175$&7
5(6($5&+25*$1,=$7,21
,19(67,*$7256321625$*5((0(17

6<1236,6
/,672)$%%5(9,$7,216$1''(),1,7,2162)7(506

6800$5<2)&+$1*(

,1752'8&7,21

'RVHDQG7UHDWPHQW'XUDWLRQ5DWLRQDOH

5LVNVDQGRU%HQHILWVWR6XEMHFWV

75,$/2%-(&7,9(6

2EMHFWLYH

(1'32,176

6DIHW\(QGSRLQWV

,19(67,*$7,21$/3/$1

2YHUDOO6WXG\'HVLJQ

6(/(&7,21',6326,7,212)678'<3238/$7,21

1XPEHURI6XEMHFWV

6WXG\3RSXODWLRQ&KDUDFWHULVWLFV

,QFOXVLRQ&ULWHULD

([FOXVLRQ&ULWHULD

&RQFRPLWDQWWKHUDSLHV

3URKLELWHGWKHUDSLHV

,QIHFWHG/HVLRQV

6XEMHFW'LVFRQWLQXDWLRQIURPWKH6WXG\

6XEMHFW,GHQWLILHU6,

5HSODFHPHQW6XEMHFWV

,19(67,*$7,21$/3/$1

6WXG\)ORZ&KDUW

6WXG\9LVLWV'HVFULSWLRQDQG3URFHGXUHV

'D\%DVHOLQH9LVLW

&\FOH6WDUW9LVLW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



0LG&\FOH9LVLW

(QGRI&\FOH9LVLW

(%6/HVLRQ,GHQWLILFDWLRQ

6XEMHFW,QVWUXFWLRQV

(%6/HVLRQ&DUH

%OLVWHUODQFLQJNLW

%DQGDJLQJ'UHVVLQJ8VH

6WXG\'XUDWLRQ

6WXG\0HGLFDWLRQV

6WXG\PHGLFDWLRQLGHQWLW\

6WXG\PHGLFDWLRQIRUPXODWLRQ

6WXG\PHGLFDWLRQSDFNDJLQJDQGODEHOLQJ

0HWKRGRIWUHDWPHQWDVVLJQPHQW

6XEMHFWWUHDWPHQWDVVLJQPHQW

'LVSHQVLQJVWXG\PHGLFDWLRQ

6WXG\PHGLFDWLRQDSSOLFDWLRQ

'RVHFRPSOLDQFHUHFRUG

'RVHPRGLILFDWLRQ

6WXG\PHGLFDWLRQ0DQDJHPHQW

$FFRXQWDELOLW\

5HWXUQDQGGLVSRVLWLRQRIVWXG\VXSSOLHV

%OLQGLQJ

9HULILFDWLRQRIEOLQGLQJ

678'<$66(660(176

6DIHW\(YDOXDWLRQV

'HPRJUDSKLFV0HGLFDO+LVWRU\

9LWDO6LJQV

&OLQLFDOODERUDWRU\VDPSOLQJ

(OHFWURFDUGLRJUDP(&*0RQLWRULQJ

3UHJQDQF\WHVWV

2WKHU(YDOXDWLRQV

&OLQLFDO$VVHVVPHQW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7RWDO9ROXPHRI%ORRG&ROOHFWHG

$'9(56((9(176

$GYHUVHHYHQWVV

$GYHUVH'UXJ5HDFWLRQ

8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQ

$VVHVVPHQWVRI$GYHUVH(YHQWVE\WKH,QYHVWLJDWRU

$VVHVVPHQWRI6HYHULW\

&DXVDOLW\$VVHVVPHQW

$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW

6HULRXV$GYHUVHHYHQWV6$(

6HULRXV$GYHUVH(YHQW$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW5HSRUWLQJ±
3URFHGXUHVIRU,QYHVWLJDWRUV

,QLWLDO5HSRUWV

)ROORZXS5HSRUWV

([SHGLWHG5HSRUWV

35(*1$1&<5(3257,1*

67$7,67,&$/$1$/<6(6

$QDO\VLV3RSXODWLRQV

'DWD$QDO\VLV

0LVVLQJ'DWD+DQGOLQJ0HWKRGV

6XEMHFW,QIRUPDWLRQ

$QDO\VLVRI6DIHW\

,QWHULP$QDO\VLV

6DPSOH6L]H&DOFXODWLRQ

',5(&7$&&(66726285&('$7$'2&80(176

6WXG\0RQLWRULQJ

(7+,&6

(WKLFV5HYLHZ

(WKLFDO&RQGXFWRIWKH6WXG\

:ULWWHQ,QIRUPHG&RQVHQW$VVHQW

'$7$+$1'/,1*$1'5(&25'.((3,1*

(OHFWURQLF&DVH5HSRUW)RUPV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



,QVSHFWLRQRI5HFRUGV

5HWHQWLRQRI5HFRUGV

38%/,&$7,2132/,&<

5()(5(1&(6
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



6<1236,6

1DPHRI6SRQVRU&RPSDQ\
&DVWOH&UHHN3KDUPDFHXWLFDOV//&
1DPHRI,QYHVWLJDWLRQDO3URGXFW
'LDFHUHLQ2LQWPHQW
1DPHRI$FWLYH,QJUHGLHQW
'LDFHUHLQ
7LWOHRI6WXG\
$Q,QWHUQDWLRQDO0XOWLFHQWHU2SHQODEHO/RQJ7HUP([WHQVLRQ6WXG\(YDOXDWLQJWKH6DIHW\
RI'LDFHUHLQ2LQWPHQW7RSLFDO)RUPXODWLRQLQ6XEMHFWVZLWK(SLGHUPRO\VLV%XOORVD
6LPSOH[(%6
6WXG\FHQWHUV$SSUR[LPDWHO\
6WXGLHGSHULRG\HDUV
(VWLPDWHGGDWHILUVWVXEMHFWHQUROOHG129
(VWLPDWHGGDWHODVWVXEMHFWFRPSOHWHG129
3KDVHRIGHYHORSPHQW

2EMHFWLYH
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRHYDOXDWHWKHORQJWHUPVDIHW\DQGWROHUDELOLW\RI
'LDFHUHLQ2LQWPHQWIRUWUHDWPHQWF\FOHVLQVXEMHFWVZLWK(%6WKDWZHUHSUHYLRXVO\
HQUROOHGLQVWXGLHV&&3RU&&3
0HWKRGRORJ\
7KLVLVDQLQWHUQDWLRQDOPXOWLFHQWHURSHQODEHOORQJWHUPH[WHQVLRQVWXG\HYDOXDWLQJWKH
VDIHW\RIWRSLFDO'LDFHUHLQ2LQWPHQWIRUWKHWUHDWPHQWRIVXEMHFWVZLWK(%6$W9LVLW
(%6VXEMHFWVZKRSDUWLFLSDWHLQWKH&&3GRXEOHEOLQGVDIHW\DQGHIILFDF\VWXG\
RUSDUWLFLSDWHLQWKH&&33.VWXG\IHHGHUVWXGLHVZKRPHHWDOOWKH
LQFOXVLRQH[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRFRPSOHWHWZRWUHDWPHQWF\FOHVRI&&3

(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPHVWXG\
PHGLFDWLRQDSSOLFDWLRQVIROORZHGE\ZHHNVRIIWUHDWPHQWRQO\LQYHVWLJDWRUDSSURYHG
EODQGQRQPHGLFDWHGHPROOLHQWPRLVWXUL]HUURXWLQHFOHDQVLQJSURGXFWVDQGVXQVFUHHQVZLWK
DPD[LPXPRIWZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRZHHNV

$W%DVHOLQHFRUUHVSRQGLQJWRWKHILQDOVWXG\YLVLWRIWKHIHHGHUVWXG\WKHLQYHVWLJDWRUZLOO
SHUIRUPDFOLQLFDODVVHVVPHQWDQGGHWHUPLQHLIDQ\RIWKHVXEMHFW¶VOHVLRQVUHTXLUHWUHDWPHQW
XSWR%6$,IWKHVXEMHFWKDVDFWLYHOHVLRQVDVGHWHUPLQHGE\WKH,QYHVWLJDWRU¶VFOLQLFDO
DVVHVVPHQWWKHVXEMHFWZLOOLQLWLDWHDF\FOHRIRQFHGDLO\DWKRPHVWXG\PHGLFDWLRQ
DSSOLFDWLRQWRWKHLU(%6OHVLRQVIRUZHHNVWUHDWPHQWSHULRGIROORZHGE\DQZHHNSHULRG
ZKHUHQRWUHDWPHQWZLOOEHDGPLQLVWHUHG6XEMHFWVSUHVHQWLQJZLWKQRDFWLYHOHVLRQVDV
GHWHUPLQHGE\WKH,QYHVWLJDWRU¶VFOLQLFDODVVHVVPHQWZLOOQRWEHJLQWUHDWPHQWDQGLQVWHDG
ZLOOEHLQVWUXFWHGWRUHWXUQWRWKHFOLQLFIRUUHHYDOXDWLRQLQZHHNVRUXSRQZRUVHQLQJRI
(%6OHVLRQVZKLFKHYHUKDSSHQVILUVW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




'XULQJWKHWUHDWPHQWSHULRGRIHDFKF\FOHVXEMHFWVFDUHJLYHUVZLOODSSO\DWKLQOD\HURIWKH
DVVLJQHGVWXG\PHGLFDWLRQVXIILFLHQWWRFRYHUWKHVXEMHFW¶V(%6OHVLRQVDQGDSSUR[LPDWHO\ô
LQFKFPRIVXUURXQGLQJXQLQYROYHGVNLQDQGJHQWO\UXELQWKHVWXG\PHGLFDWLRQ
6XEMHFWVFDUHJLYHUVZLOODSSO\WKHDVVLJQHGVWXG\PHGLFDWLRQWRDOO(%6OHVLRQVLQFOXGLQJ
DQ\QHZ(%6OHVLRQVWKDWGHYHORSXSWR%6$RQFHGDLO\HYHU\HYHQLQJXQWLOWKH
OHVLRQVUHVROYHIRUZHHNV$IWHUZHHNVWKHVXEMHFWZLOOUHWXUQWRWKHVLWHWRUHWXUQWKH
VWXG\PHGLFDWLRQDQGUHPDLQRIIVWXG\PHGLFDWLRQIRUZHHNV7KHLQYHVWLJDWRUZLOOUH
HYDOXDWHWKHVXEMHFWDIWHUWKHZHHNVRIIWKHUDS\DQGLIDQ\RIWKHVXEMHFW¶VOHVLRQVUHTXLUH
WUHDWPHQWXSWR%6$WKHVXEMHFWZLOOEHJLQDQRWKHUWUHDWPHQWF\FOHIRUDPD[LPXPRI
WZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRZHHNV

6DIHW\ZLOOEHPRQLWRUHGWKURXJKRXWWKHVWXG\E\UHSHDWHGFOLQLFDODQGODERUDWRU\
HYDOXDWLRQVYLWDOVLJQV(&*PRQLWRULQJDQGDGYHUVHHYHQWPRQLWRULQJ

7KHGXUDWLRQRIDVXEMHFW¶VSDUWLFLSDWLRQLQWKHH[WHQVLRQVWXG\PD\EHDVVKRUWDVZHHNV
RUDVORQJDVZHHNVGHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGXOH6XEMHFWVPD\QRWVWDUWD
QHZWUHDWPHQWF\FOHSDVW:HHNIURP%DVHOLQH9LVLWZLWKRXWSULRUVSRQVRUDSSURYDO
1XPEHURIVXEMHFWVSODQQHG
$SSUR[LPDWHO\VXEMHFWVDUHH[SHFWHGWREHHQUROOHGLQWKLVVWXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXEMHFWVWKDWDUHHQUROOHGZLOO
GHSHQGRQWKHILQDOQXPEHURI(%6VXEMHFWVZKRSDUWLFLSDWHLQWKH&&3RU
SDUWLFLSDWHLQWKH&&3VWXG\
'LDJQRVLVDQGPDLQFULWHULDIRULQFOXVLRQH[FOXVLRQ
,QFOXVLRQFULWHULD
 6XEMHFWKDVDGRFXPHQWHGJHQHWLFPXWDWLRQFRQVLVWHQWZLWK(%6
 6XEMHFWVZKRSDUWLFLSDWHGLQWKH&&3RUWKH&&3VWXG\DUHHOLJLEOH
WREHUROOHGLQWRWKH&&3RSHQODEHOH[WHQVLRQVWXG\UHJDUGOHVVRIWKHLU
FRPSOHWLRQVWDWXVRQWKHIHHGHUVWXG\
 6XEMHFWFDUHJLYHUDJUHHVWRUHSRUWXVHRIDQ\WRSLFDOWKHUDSLHVDSSOLHGWR(%6OHVLRQV
HJPHGLFDWHGFOHDQVHUVEOHDFKEDWKVWRSLFDODQWLVHSWLFVWRSLFDOGLVLQIHFWDQWV
WRSLFDOVWHURLGVHWF
 ,IWKHVXEMHFWLVDZRPDQRIFKLOGEHDULQJSRWHQWLDOVKHKDVDQHJDWLYHXULQH
SUHJQDQF\WHVWDQGDJUHHVWRXVHDQDSSURYHGHIIHFWLYHPHWKRGRIELUWKFRQWURODV
GHILQHGE\WKLVSURWRFROVHH6HFWLRQIRUWKHGXUDWLRQRIWKHVWXG\
 6XEMHFWLVQRQODFWDWLQJDQGLVQRWSODQQLQJIRUSUHJQDQF\GXULQJWKHVWXG\SHULRG
 6XEMHFWLVZLOOLQJDQGDEOHWRIROORZDOOVWXG\LQVWUXFWLRQVDQGWRDWWHQGDOOVWXG\YLVLWV
 6XEMHFWFDUHJLYHULVDEOHWRFRPSUHKHQGDQGZLOOLQJWRVLJQDQ,QIRUPHG&RQVHQW
DQGRU$VVHQW)RUP
([FOXVLRQFULWHULD
6XEMHFWKDV(%6OHVLRQVWREHWUHDWHGWKDWDUHLQIHFWHGLH(%6OHVLRQVWKDWUHTXLUH
WKHUDS\WRWUHDWDQLQIHFWLRQ
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



 6XEMHFWKDVHYLGHQFHRIDV\VWHPLFLQIHFWLRQRUKDVXVHGV\VWHPLFDQWLELRWLFVZLWKLQ
GD\VSULRUWR%DVHOLQH
 7KHVXEMHFWZDVGLVFRQWLQXHGIURPWKHIHHGHUVWXG\GXHWRDQDGYHUVHHYHQW
 6XEMHFWKDVH[SHULHQFHGDFKDQJHLQFOLQLFDOVWDWXVIURPWKHIHHGHUVWXG\WKDWLQWKH
LQYHVWLJDWRU¶VRSLQLRQSXWVWKHVXEMHFWDWXQGXHULVNWRSDUWLFLSDWH
,QYHVWLJDWLRQDOSURGXFWGRVDJHDQGPRGHRIDGPLQLVWUDWLRQ
'LDFHUHLQ2LQWPHQWDGPLQLVWHUHGWRSLFDOO\RQFHGDLO\
'XUDWLRQRIVWXG\DQGWUHDWPHQW
$SSUR[LPDWHO\ZHHNV
5HIHUHQFHWKHUDS\GRVDJHDQGPRGHRIDGPLQLVWUDWLRQ
1RWDSSOLFDEOH(YHU\VXEMHFWRQWKLVVWXG\ZLOOEHDVVLJQHGWR'LDFHUHLQ2LQWPHQW
6DIHW\HYDOXDWLRQV
$VVHVVPHQWRIDGYHUVHHYHQWV(&*VYLWDOVLJQVFOLQLFDODVVHVVPHQWDQGODERUDWRU\WHVWVZLOO
EHSHUIRUPHGWKURXJKRXWWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



/,672)$%%5(9,$7,216$1''(),1,7,2162)7(506

$EEUHYLDWLRQ
7HUP
$(
$GYHUVH(YHQW
$/7
$ODQLQH$PLQRWUDQVIHUDVH
$1&29$
$QDO\VLVRI&RYDULDQFH
$67
$VSDUWDWH$PLQRWUDQVIHUDVH
%6$
%RG\6XUIDFH$UHD
&
'HJUHHV&HQWLJUDGH
&0+
&RFKUDQ0DQWHO+DHQV]HO
&5
&OLQLFDOO\5HOHYDQW
&5$
&OLQLFDO5HVHDUFK$VVRFLDWH
&5)
&DVH5HSRUW)RUP
&52
&RQWUDFW5HVHDUFK2UJDQL]DWLRQ
(%6
(SLGHUPRO\VLV%XOORVD6LPSOH[
HJ
)RU([DPSOH/DWLQH[HPSODJUDWLD
(&
(WKLFV&RPPLWWHH
&5)
&DVH5HSRUW)RUP
('&
(OHFWURQLF'DWD&DSWXUH
'(%
'\VWURSKLF(SLGHUPRO\VLV%XOORVD
)
'HJUHHV)DKUHQKHLW
)'$
)RRGDQG'UXJ$GPLQLVWUDWLRQ
*
*UDP
*&3
*RRG&OLQLFDO3UDFWLFH
+&*
+XPDQ&KRULRQLF*RQDGRWURSKLQ
+,3$$
+HDOWK,QVXUDQFH3RUWDELOLW\DQG$FFRXQWDELOLW\$FWRI
+J
0HUFXU\
,%
,QYHVWLJDWRU¶V%URFKXUH
,&)
,QIRUPHG&RQVHQW)RUP
,&+
,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQL]DWLRQ
LH
7KDW,V/DWLQLGHVW
,*$
,QYHVWLJDWRU¶V*OREDO$VVHVVPHQW
,5%
,QVWLWXWLRQDO5HYLHZ%RDUG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



$EEUHYLDWLRQ

7HUP
,57
,QWHUDFWLYH5HVSRQVH7HFKQRORJ\
,77
,QWHQW7R7UHDW
/2&)
/DVW2EVHUYDWLRQ&DUULHG)RUZDUG
/6$
/HVLRQ6XUIDFH$UHD
0HG'5$
0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV
0O
0LOOLOLWHU
0P
0LOOLPHWHU
0RO
0LFURPRODU
1&5
1RW&OLQLFDOO\5HOHYDQW
156
1XPHULF5DWLQJ6FDOH
27&
2YHU7KH&RXQWHU
351
$VQHHGHG
33
3HU3URWRFRO
6$(
6HULRXV$GYHUVH(YHQW
6,
6XEMHFW,GHQWLILHU
623
6WDQGDUG2SHUDWLRQ3URFHGXUH
86
8QLWHG6WDWHV
:2&%3
:RPHQRIFKLOGEHDULQJSRWHQWLDO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6800$5<2)&+$1*(

6HFWLRQ
'HVFULSWLRQ
RI&KDQJH
5DWLRQDOH
6LJQDWXUH
SDJH
&RQWHQW
PRGLILHG
1HZWLWOHDQGUHSUHVHQWDWLYH
6SRQVRU¶V
FRQWDFW
LQIRUPDWLRQ
&RQWHQW$GGHG
6SRQVRU¶VFRQWDFWLQIRUPDWLRQSDJHDGGHGWRLQFOXGHQHZ
6SRQVRU3K\VLFLDQDQGWHDPPHPEHUV8SGDWHGWRLQFOXGH
QHZ&520HGLFDO0RQLWRU
6\QRSVLV
&RQWHQW
PRGLILHG
8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
6\QRSVLV
&RQWHQW
PRGLILHG
,QFOXVLRQ&ULWHULD&ODULILFDWLRQUHJDUGLQJDOORZLQJQRW
RQO\IHHGHUVWXG\FRPSOHWHUVLQWRWKHVWXG\EXWDOORZLQJDOO
VXEMHFWVZKRSDUWLFLSDWHGWRHQUROO

&RQWHQW
PRGLILHG
8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\

&RQWHQW
PRGLILHG
8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\

&RQWHQW
PRGLILHG
&ODULILFDWLRQUHJDUGLQJDOORZLQJDOO(%6VXEMHFWVRQDQG
WRHQWHUWKHH[WHQVLRQVWXG\

&RQWHQW
PRGLILHG
,QFOXVLRQ&ULWHULD&ODULILFDWLRQUHJDUGLQJDOORZLQJQRW
RQO\IHHGHUVWXG\FRPSOHWHUVLQWRWKHVWXG\EXWDOORZLQJDOO
VXEMHFWVZKRSDUWLFLSDWHGWRHQUROO

&RQWHQW
PRGLILHG
&ODULILFDWLRQUHJDUGLQJSDUWLFLSDWLRQRQWKHVWXG\

&RQWHQW
PRGLILHG
8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




,1752'8&7,21
(SLGHUPRO\VLVEXOORVDVLPSOH[(%6LVDUDUHJHQHWLFVNLQGLVHDVHFKDUDFWHUL]HGE\IUDJLOLW\RI
WKHVNLQDQGPXFRXVPHPEUDQHVUHVXOWLQJLQSDLQIXOEOLVWHUVDQGHURVLRQVDIWHUPLQRUWUDXPD
DQGLVDVVRFLDWHGZLWKVLJQLILFDQWPRUELGLW\DQGPRUWDOLW\(%6LVERWKDSHGLDWULFDQGDQDGXOW
GLVHDVHWKDWWHQGVWRDIIHFW\RXQJHUSDWLHQWVPRVWVHYHUHO\0RVWSDWLHQWVZLWK(%6KDYHWR
RIERG\VXUIDFHDUHD%6$DIIHFWHGE\EOLVWHUVDOWKRXJKWKHUHFDQEHZLGHYDULDWLRQV(%6
IUHTXHQWO\KDVSDOPDUDQGSODQWDULQYROYHPHQWZKLFKFDQVLJQLILFDQWO\DIIHFWSDWLHQWV¶PRELOLW\
DQGTXDOLW\RIOLIH,QDGGLWLRQWREOLVWHULQJDQGVNLQLQIHFWLRQVSDWLHQWVVXIIHUIURPSDLQDQG
VHYHUHFRQWLQXRXVLWFKLQJ7KHUHDUHFXUUHQWO\QRDSSURYHGWUHDWPHQWVIRU(%6
7KHVLPSOH[IRUPLVRIPDMRUW\SHVRI(%DQGLVFODVVLILHGE\VNLQEOLVWHUGHYHORSPHQWLQWKH
EDVDOHSLGHUPLV7KRVHERUQZLWK(%DUHRIWHQFDOOHG³%XWWHUIO\&KLOGUHQ´EHFDXVHDVWKH
DQDORJ\JRHVWKHLUVNLQLVDVIUDJLOHDVWKHZLQJVRIDEXWWHUIO\7KHSUHYDOHQFHRILQKHULWHG(%
LQWKH86LVHVWLPDWHGWREHDSSUR[LPDWHO\SHUPLOOLRQOLYHELUWKVDFFRUGLQJWRWKH1DWLRQDO
(SLGHUPRO\VLV%XOORVD5HJLVWU\LQWKH86WKHUHDUHDURXQGQHZ(%FDVHVSHUPLOOLRQOLYH
ELUWKVRIZKLFKDSSUR[LPDWHO\DUH(%6
'LDFHUHLQ2LQWPHQWLVDWRSLFDORLQWPHQWFRQWDLQLQJGLDFHUHLQELV>DFHW\OR[\@
GLK\GURGLR[RDQWKUDFHQHFDUER[\OLFDFLGDOVRNQRZQDVGLDFHW\OUKHLQDKLJKO\
SXULILHGDQWKUDTXLQRQHGHULYDWLYHDQGLVEHLQJGHYHORSHGIRUWKHWUHDWPHQWRI(%67KHFDSVXOH
IRUPXODWLRQRIGLDFHUHLQLQWHQGHGIRURUDOXVHDQGV\VWHPLFDEVRUSWLRQZDVLQLWLDOO\DSSURYHG
IRUXVHLQRVWHRDUWKULWLV2$LQ)UDQFHLQDV$UWRGDU$57RU=RQGDU6LQFHWKHQ
LWKDVUHFHLYHGPDUNHWLQJDXWKRUL]DWLRQLQRYHUFRXQWULHVLQ(XURSH6RXWK$PHULFDDQG$VLD
,WLVFODVVLILHGDVD6\PSWRPDWLF6ORZ$FWLQJ'UXJLQ2$)ROORZLQJRUDODGPLQLVWUDWLRQRIWKH
FDSVXOHIRUPXODWLRQGLDFHUHLQLVUDSLGO\PHWDEROL]HGWRWKHGHDFHW\ODWHGDFWLYHPHWDEROLWHUKHLQ
6LPLODUO\GLDFHUHLQLQWKHWRSLFDOIRUPXODWLRQLVK\GURO\]HGWRUKHLQLQWKHHSLGHUPLVDQGGHUPLV
IROORZLQJDGPLQLVWUDWLRQ'LDFHUHLQDQGUKHLQKDYHEHHQVKRZQWRLQKLELWWKHLQYLWURDQGLQYLYR
SURGXFWLRQDQGDFWLYLW\RILQWHUOHXNLQȕ,/ȕDQGRWKHUSURLQIODPPDWRU\F\WRNLQHV,WKDVD
QRYHOPRGHRIDFWLRQWKDWGLIIHUHQWLDWHVLWIURPQRQVWHURLGDODQWLLQIODPPDWRU\GUXJV16$,'V
DQGRWKHUFRQYHQWLRQDOIRUPVRIGUXJWKHUDS\
,/ȕLVDSURLQIODPPDWRU\F\WRNLQHWKDWKDVEHHQOLQNHGWRDQXPEHURILQIODPPDWRU\DQG
DXWRLPPXQHGLVHDVHVLQFOXGLQJUKHXPDWRLGDUWKULWLV5$2$KHPRSKLOLFDUWKURSDWK\JRXW\
DUWKULWLVW\SHGLDEHWHVPHOOLWXV7'0GLDEHWLFQHSKURSDWK\'1DQG(%6,QYLWURDQGLQ
YLYRDQLPDOVWXGLHVKDYHVKRZQWKDWERWKGLDFHUHLQDQGLWVDFWLYHPHWDEROLWHUKHLQLQKLELWWKH
SURGXFWLRQDQGDFWLYLW\RISURLQIODPPDWRU\DQGSURFDWDEROLFF\WRNLQHVVXFKDV,/DQG,/
DQGWKHH[SUHVVLRQRILQGXFLEOHQLWULFR[LGHV\QWKDVHL126DQGWXPRUQHFURVLVIDFWRUĮ71)
Į
3ULRUWRWKHILUVWDSSOLFDWLRQRIGLDFHUHLQLQDSKDVH(%6WUHDWPHQWVWXG\DVLQJOHWRSLFDO
DSSOLFDWLRQRIPJ'LDFHUHLQ&UHDPZDVDSSOLHGWRWKHVNLQRIDSDWLHQWZLWK(%67KH
DPRXQWRIUKHLQGHWHFWHGLQWKHSDWLHQW¶VXULQHZDVRIWKHDPRXQWGHWHFWHGLQWKHXULQHDIWHU
RUDODGPLQLVWUDWLRQRIWKHVDPHGRVH3KDUPDFRNLQHWLF3.DQDO\VLVRIUKHLQZDVSHUIRUPHGLQ
SDWLHQWVZLWK(%6IURPWKHSKDVHWULDOGHVFULEHGEHORZ6HUXPDQGXULQHVDPSOHVZHUH
FROOHFWHGLPPHGLDWHO\IROORZLQJZHHNVRIDGPLQLVWUDWLRQRI'LDFHUHLQ&UHDPWRRI
WKHVHSDWLHQWV%6$7KHKLJKHVWOHYHORIUKHLQLQXULQHZDVQJPODQGWKHKLJKHVWOHYHORI
UKHLQLQVHUXPZDVQJPO7KLVVHUXPOHYHOUHSUHVHQWVOHVVWKDQRIWKHVHUXPOHYHO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



GHWHFWDEOHDIWHURUDODGPLQLVWUDWLRQRIDVLQJOHGRVHRIPJGLDFHUHLQ7KHVHGDWDVXJJHVWWKDW
XSRQWRSLFDODGPLQLVWUDWLRQGLDFHUHLQUHDFKHVFLUFXODWLRQLQWKHIRUPRIUKHLQDQGLVH[FUHWHGDV
UKHLQ$GGLWLRQDOO\WKHPRVWFRPPRQO\UHSRUWHGDGYHUVHHIIHFWVDIWHURUDODGPLQLVWUDWLRQVXFK
DVGLDUUKHDQDXVHDDQGYRPLWLQJRFFXUDWRQO\KLJKHUV\VWHPLFFRQFHQWUDWLRQVZKLFKVKRXOG
QRWEHDFKLHYHGIROORZLQJWRSLFDODGPLQLVWUDWLRQ
3KDVHDQGSKDVHVWXGLHVRI'LDFHUHLQ&UHDPIRUWUHDWPHQWRI(%6KDYHEHHQVXFFHVVIXOO\
FRPSOHWHG%RWKVWXGLHVZHUHFRQGXFWHGLQ(XURSHXQGHU'U-RKDQQ%DXHUDVSULQFLSDO
LQYHVWLJDWRU
$SKDVHFOLQLFDOSLORWVWXG\RIWRSLFDO'LDFHUHLQ&UHDPWRUHGXFHEOLVWHULQJLQSDWLHQWVZLWK
(%6'0JHQHUDOL]HGVHYHUHW\SHZDVFRPSOHWHGLQDQGLWVUHVXOWVZHUHSXEOLVKHGLQ
)LYHSDWLHQWVZLWK(%6'0LQLWLDOO\DSSOLHG'LDFHUHLQ&UHDPXQGHUQHDWKERWK
DUPSLWVLQWKHILUVWZHHNRSHQODEHOSKDVH7KHQHDFKSDUWLFLSDQWUHFHLYHG'LDFHUHLQ
&UHDPIRURQHDUPSLWDQGSODFHERIRUWKHRWKHULQDVHFRQGUDQGRPL]HGSODFHERFRQWUROOHG
ZHHNSKDVH7LPHWRORVVRIHIILFDF\GHILQHGDVKDOYLQJRIWKHHIIHFWREVHUYHGLQSKDVHZDV
FKRVHQDVWKHSULPDU\HQGSRLQW5HVXOWVVKRZHGDVWDWLVWLFDOO\VLJQLILFDQWUHGXFWLRQRIEOLVWHUV
ZLWKLQWKHILUVWZHHNVRIWKHRSHQODEHOSKDVH,QSKDVHWKHUHZDVQRORVVRIHIILFDF\LQ
ERWKWKHWUHDWHGDQGSODFHERJURXSV
$SKDVHFOLQLFDOVWXG\ZDVFRPSOHWHGLQ7KLVZDVDSODFHERFRQWUROOHGUDQGRPL]HGDQG
GRXEOHEOLQGHGFURVVRYHUVWXG\RIUDQGRPL]HGDQGWUHDWHGSDWLHQWVDJHVWRGLDJQRVHG
ZLWKJHQHUDOL]HGVHYHUH(%6$ZHHNWUHDWPHQWSHULRGDQGDWKUHHPRQWKIROORZXSSHULRG
ZDVSHUIRUPHGLQERWK<HDUDQG<HDURIWKHVWXG\ZLWKDFURVVRYHURIJURXSVSODFHERDQG
GLDFHUHLQEHWZHHQ\HDUV'XULQJWKHZHHNWUHDWPHQWSHULRGSDWLHQWVRUWKHLUFDUHJLYHUV
DSSOLHGILQJHUWLSXQLWVRI'LDFHUHLQ&UHDPRUSODFHERRQWRDSUHGHILQHGVNLQDUHD7KUHH
SHUFHQWRIWKHWRWDO%6$ZDVFKRVHQWRJHWKHUZLWKWKHSDWLHQWVZLWKWKHSUHUHTXLVLWHWKDW
VLJQLILFDQWQXPEHUVRIEOLVWHUVZHUHSUHVHQWDW7LPH
7KHUHVXOWVRIWKHVHVWXGLHVVXJJHVWWKDWWRSLFDOGLDFHUHLQKDVWKHSRWHQWLDOWRGRZQUHJXODWHWKH
DFWLYLW\RI,/ȕDQGUHGXFHWKHLQIODPPDWRU\HIIHFWVLQWKHVNLQRISDWLHQWVZLWK(%67KH
IDYRUDEOHSURGXFWSURILOHRIGLDFHUHLQDQDQWL,/ȕVPDOOPROHFXOHSURYLGHVDUDWLRQDOHIRU
LQYHVWLJDWLQJWKHFOLQLFDOXWLOLW\LQUHGXFLQJWKHIUHTXHQF\RUSUHYHQWLQJRIEOLVWHUIRUPDWLRQLQ
SDWLHQWVZLWK(%6
'HWDLOHGLQIRUPDWLRQDERXWWKHSKDVHDQGSKDVHVWXG\GHVLJQVDQGUHVXOWVDUHSUHVHQWHGLQWKH
'LDFHUHLQ7RSLFDO2LQWPHQW,QYHVWLJDWRU¶V%URFKXUH
7KLVVWXG\LVDQRSHQODEHOORQJWHUPH[WHQVLRQRIVWXGLHV&&3DUDQGRPL]HG
GRXEOHEOLQGSKDVH,,VWXG\HYDOXDWLQJWKHHIILFDF\DQGVDIHW\RI'LDFHUHLQ2LQWPHQWLQ
VXEMHFWVZLWK(%6DQG&&3DSKDVH,VWXG\HYDOXDWLQJWKHSKDUPDFRNLQHWLFVRI
'LDFHUHLQ2LQWPHQWLQVXEMHFWVZLWK(%6DQGKHDOWK\YROXQWHHUV6XEMHFWVZKRSDUWLFLSDWH
LQWKH&&3RUWKH&&3VWXG\DUHHOLJLEOHWREHUROOHGLQWRWKH&&3
RSHQODEHOH[WHQVLRQVWXG\UHJDUGOHVVRIWKHLUFRPSOHWLRQVWDWXVRQWKHIHHGHUVWXG\


'RVHDQG7UHDWPHQW'XUDWLRQ5DWLRQDOH
,QDGGLWLRQWRWKHORQJKLVWRU\RIFOLQLFDOH[SHULHQFHZLWKGLDFHUHLQDIWHURUDODGPLQLVWUDWLRQ
VWXGLHVZLWKWRSLFDOGLDFHUHLQKDYHEHHQFRQGXFWHG5HVXOWVIURPDZHHNSKDVHSLORW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI


VWXG\LQ(%6'0SDWLHQWVGHPRQVWUDWHGDVXEVWDQWLDOUHGXFWLRQLQEOLVWHUVDIWHUZHHNVRI
GDLO\DSSOLFDWLRQRIGLDFHUHLQFUHDP,QWKLVVWXG\WUHDWPHQWFRQWLQXHGRSHQODEHOIRUDQ
DGGLWLRQDOZHHNV,QSHULRGRIWKHVWXG\WKHHIIHFWVODVWHGDQDGGLWLRQDOZHHNVLQSDWLHQWV
DGPLQLVWHUHGGLDFHUHLQRUSODFHERLQGLFDWLQJDGXUDEOHUHVSRQVHIURPWKHLQLWLDORSHQODEHO
ZHHNWUHDWPHQWSHULRG7KHUHZHUHQRDGYHUVHHYHQWVUHSRUWHGGXULQJWKHVWXG\
$PXOWLFHQWHU(XURSHDQSKDVHSODFHERFRQWUROOHGUDQGRPL]HGGRXEOHEOLQGFURVVRYHU
VWXG\RI(%6SDWLHQWVDJHGWRZDVFRPSOHWHG7KHVWXG\ZDVUXQRYHU\HDUVZLWKD
ZHHNWUHDWPHQWSHULRGDQGPRQWKIROORZXSSHULRGLQHDFK\HDURIWKHVWXG\GLDFHUHLQ
FUHDPRUSODFHER,QWKLVVWXG\WKHGRVHGRVHGXUDWLRQZHHNVDQGDSSOLFDWLRQDUHD
%6$HVWDEOLVKHGDKLJKO\VLJQLILFDQWUHGXFWLRQLQEOLVWHUFRXQWVLQERWK\HDUVRIWUHDWPHQW
DWWKHHQGRIWKHZHHNWUHDWPHQWSHULRGDVZHOODVFRQWLQXHGUHVSRQVHDWPRQWKVSRVW
WUHDWPHQWFRPSDUHGWRSODFHER6HFRQGDU\HQGSRLQWVDOVRGHPRQVWUDWHGDQHIIHFWRIWKH
WUHDWPHQWDUPFRPSDUHGWRSODFHERDVPHDVXUHGE\WLPHWRUHDFKLQLWLDOEOLVWHUFRXQWVDQG
SDWLHQWUHSRUWHGRXWFRPHVRILPSURYHPHQWVLQSDLQDQGLWFKLQJ7KHUHZHUHQRGUXJUHODWHG
$(VLQWKHVWXG\DQGQRGLVFRQWLQXDWLRQVUHODWHGWRWUHDWPHQW
7KHVHSUHOLPLQDU\FOLQLFDOVWXGLHVGHPRQVWUDWHGSURRIRIFRQFHSWHIILFDF\RIDGLDFHUHLQ
FUHDPLQ(%6'0SDWLHQWV7KLVFXUUHQWWULDOZLOOVHHNWRHVWDEOLVKORQJWHUPVDIHW\DQG
WROHUDELOLW\RIDGLDFHUHLQRLQWPHQWLQSDWLHQWVZLWK(%6
6XEMHFWVHQWHULQJWKHRSHQODEHOORQJWHUPH[WHQVLRQVWXG\DIWHUFRPSOHWLQJWKH&&3
RU&&3VWXGLHVZLOOKDYHEHHQH[SRVHGWRWUHDWPHQWZLWKGLDFHUHLQRLQWPHQWRU
SODFHER

5LVNVDQGRU%HQHILWVWR6XEMHFWV
7KHGRVHRIVWXG\PHGLFDWLRQDGPLQLVWHUHGLQWKLVVWXG\LVDQWLFLSDWHGWRLQGXFHWKHUDSHXWLF
EHQHILWZLWKSURORQJHGWUHDWPHQW,WLVDQWLFLSDWHGWKDWFRQWLQXHGXVHRIWKHVWXG\PHGLFDWLRQ
ZHHNVRQZHHNVRIIZLOOUHGXFHWKHEOLVWHUVHYHULW\RIWKHDIIHFWHGDUHD$GGLWLRQDOO\VXEMHFWV
ZLOOUHFHLYHVWXG\PHGLFDWLRQDWQRFRVWIRUWKHGXUDWLRQRIWKHVWXG\
7KHVDIHW\PRQLWRULQJSUDFWLFHVHPSOR\HGE\WKLVSURWRFROLHYLWDOVLJQVFOLQLFDODQG
ODERUDWRU\HYDOXDWLRQV(&*VDQG$(TXHVWLRQLQJDUHDGHTXDWHWRSURWHFWWKHVXEMHFWV¶VDIHW\
DQGDUHH[SHFWHGWREHVXIILFLHQWWRGHWHFWDOOWUHDWPHQWHPHUJHQWDGYHUVHHYHQWV7($(V
7KHDSSUR[LPDWHYROXPHRIEORRGSODQQHGIRUFROOHFWLRQIURPHDFKVXEMHFWRYHUWKHFRXUVHRIWKH
VWXG\LVQRWFRQVLGHUHGWRSUHVHQWXQGXHULVNWRWKHVXEMHFWV1RIXUWKHUULVNLVSUHVHQWLI
DGGLWLRQDOEORRGLVUHTXLUHGIRUUHFKHFNRIVDIHW\ODERUDWRU\WHVWVDVGHHPHGQHFHVVDU\E\WKH3,
$QLQGLUHFWKHDOWKEHQHILWWRWKH(%6VXEMHFWVHQUROOHGLQWKLVWULDOLVWKHPHGLFDOWHVWLQJUHFHLYHG
DWVFUHHQLQJDQGGXULQJWKHVWXG\DVRXWOLQHGLQWKLVSURWRFROZLOOEHSURYLGHGDWQRFRVWWRWKH
VXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




75,$/2%-(&7,9(6

2EMHFWLYH
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRHYDOXDWHWKHORQJWHUPVDIHW\DQGWROHUDELOLW\RI
'LDFHUHLQ2LQWPHQWLQVXEMHFWVZLWK(%6WKDWZHUHSUHYLRXVO\HQUROOHGLQVWXGLHV&&3
RU&&3
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




(1'32,176

6DIHW\(QGSRLQWV
6DIHW\ZLOOEHHYDOXDWHGLQWHUPVRIWKHRFFXUUHQFHRI$(VDQGFKDQJHVLQFOLQLFDOODERUDWRU\
SDUDPHWHUVFOLQLFDOH[DPLQDWLRQILQGLQJVYLWDOVLJQVZHLJKWDQGXULQHPHDVXUHPHQWV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




,19(67,*$7,21$/3/$1

2YHUDOO6WXG\'HVLJQ
7KLVLVDQLQWHUQDWLRQDOPXOWLFHQWHURSHQODEHOORQJWHUPH[WHQVLRQVWXG\HYDOXDWLQJWKHVDIHW\
RIWRSLFDO'LDFHUHLQ2LQWPHQWIRUWKHWUHDWPHQWRIVXEMHFWVZLWK(%6$W%DVHOLQH(%6
VXEMHFWVZKRSDUWLFLSDWHGWKH&&3GRXEOHEOLQGVDIHW\DQGHIILFDF\VWXG\RU
SDUWLFLSDWHGLQWKH&&33.VWXG\IHHGHUVWXGLHVDQGZKRPHHWDOOWKH
LQFOXVLRQH[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRHQUROOLQWKLVVWXG\
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPHVWXG\PHGLFDWLRQ
DSSOLFDWLRQVIROORZHGE\ZHHNVRIIWUHDWPHQWZLWKDPD[LPXPRIWZRWUHDWPHQWF\FOHV
DOORZHGIRUXSWRZHHNV
$W%DVHOLQHFRUUHVSRQGLQJWRWKHILQDOVWXG\YLVLWRIWKHIHHGHUVWXG\WKHLQYHVWLJDWRUZLOO
SHUIRUPDFOLQLFDODVVHVVPHQWDQGGHWHUPLQHLIDQ\RIWKHVXEMHFW¶VOHVLRQVUHTXLUHWUHDWPHQWXS
WR%6$,IWKHVXEMHFWKDVDFWLYHOHVLRQVDVGHWHUPLQHGE\WKH,QYHVWLJDWRU¶VFOLQLFDO
DVVHVVPHQWWKHVXEMHFWZLOOLQLWLDWHDF\FOHRIRQFHGDLO\DWKRPHVWXG\PHGLFDWLRQDSSOLFDWLRQ
WRWKHLU(%6OHVLRQVIRUZHHNVWUHDWPHQWSHULRGIROORZHGE\DQZHHNSHULRGZKHUHQR
WUHDWPHQWZLOOEHDGPLQLVWHUHG6XEMHFWVSUHVHQWLQJZLWKQRDFWLYHOHVLRQVDVGHWHUPLQHGE\WKH
,QYHVWLJDWRU¶VFOLQLFDODVVHVVPHQWZLOOQRWEHJLQWUHDWPHQWDQGLQVWHDGZLOOEHLQVWUXFWHGWRUHWXUQ
WRWKHFOLQLFIRUUHHYDOXDWLRQLQZHHNVRUXSRQZRUVHQLQJRI(%6OHVLRQVZKLFKHYHUKDSSHQV
ILUVW
'XULQJWKHWUHDWPHQWSHULRGRIHDFKF\FOHVXEMHFWVFDUHJLYHUVZLOODSSO\DWKLQOD\HURIWKH
DVVLJQHGVWXG\PHGLFDWLRQVXIILFLHQWWRFRYHUWKHVXEMHFW¶V(%6OHVLRQVDQGDSSUR[LPDWHO\ô
LQFKFPRIVXUURXQGLQJXQLQYROYHGVNLQDQGJHQWO\UXELQWKHVWXG\PHGLFDWLRQ
6XEMHFWVFDUHJLYHUVZLOODSSO\WKHDVVLJQHGVWXG\PHGLFDWLRQWRDOO(%6OHVLRQVLQFOXGLQJDQ\
QHZ(%6OHVLRQVWKDWGHYHORSXSWR%6$RQFHGDLO\HYHU\HYHQLQJXQWLOWKHOHVLRQV
UHVROYHIRUZHHNV$IWHUZHHNVWKHVXEMHFWZLOOUHWXUQWRWKHVLWHWRUHWXUQWKHVWXG\
PHGLFDWLRQDQGUHPDLQRIIWUHDWPHQWIRUZHHNV7KHLQYHVWLJDWRUZLOOUHHYDOXDWHWKHVXEMHFW
DIWHUZHHNVRIIWKHUDS\DQGLIDQ\RIWKHVXEMHFW¶VOHVLRQVUHTXLUHWUHDWPHQWXSWR%6$
WKHVXEMHFWZLOOEHJLQDQRWKHUWUHDWPHQWF\FOHIRUDPD[LPXPRIWZRWUHDWPHQWF\FOHVDOORZHG
IRUXSWRZHHNV
6DIHW\ZLOOEHPRQLWRUHGWKURXJKRXWWKHVWXG\E\UHSHDWHGFOLQLFDODQGODERUDWRU\HYDOXDWLRQV
YLWDOVLJQV(&*PRQLWRULQJDQGDGYHUVHHYHQWPRQLWRULQJ
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWIROORZHGE\ZHHNVRIIWUHDWPHQW
ZLWKDPD[LPXPRIWZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRZHHNV6XEMHFWVVKRXOGEH
DVVHVVHGDWPLQLPXPHYHU\ZHHNVIRUGLVHDVHDFWLYLW\2QFHDVXEMHFWFRPSOHWHVWZRF\FOHVRI
WUHDWPHQWRUUHDFKHV:HHNWKHVXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWXG\6XEMHFWVPD\QRW
VWDUWDQHZWUHDWPHQWF\FOHSDVW:HHNZLWKRXWSULRUVSRQVRUDSSURYDO7KHGXUDWLRQRID
VXEMHFW¶VSDUWLFLSDWLRQLQWKHH[WHQVLRQVWXG\PD\EHDVVKRUWDVZHHNVRUDVORQJDVZHHNV
GHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGXOHIRUHDFKLQGLYLGXDOVXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6(/(&7,21',6326,7,212)678'<3238/$7,21

1XPEHURI6XEMHFWV
$SSUR[LPDWHO\VXEMHFWVDUHDQWLFLSDWHGWREHHQUROOHGLQWKLVVWXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXEMHFWVWKDWDUHHQUROOHGLQWRWKH
&&3VWXG\ZLOOGHSHQGRQWKHILQDOQXPEHURI(%6VXEMHFWVZKRSDUWLFLSDWHGLQWKH
&&3RU&&3VWXG\

6WXG\3RSXODWLRQ&KDUDFWHULVWLFV
6XEMHFWVHQUROOHGLQWKHH[WHQVLRQVWXG\ZLOOKDYHJHQHWLFFRQILUPDWLRQRI(%6YHULILHGLQWKH
IHHGHUVWXG\


,QFOXVLRQ&ULWHULD
,QRUGHUWREHHOLJLEOHIRUWKHVWXG\VXEMHFWVPXVWIXOILOODOORIWKHIROORZLQJFULWHULD
 ,QWKHRSLQLRQRIWKH,QYHVWLJDWRUWKHVXEMHFWLVFDSDEOHRIXQGHUVWDQGLQJDQGFRPSO\LQJ
ZLWKSURWRFROUHTXLUHPHQWV
 7KHVXEMHFWRUZKHQDSSOLFDEOHWKHVXEMHFW
VOHJDOO\DFFHSWDEOHUHSUHVHQWDWLYHVLJQVDQG
GDWHVDZULWWHQLQIRUPHGFRQVHQWDVVHQWIRUPDQGDQ\UHTXLUHGSULYDF\DXWKRUL]DWLRQ
SULRUWRWKHLQLWLDWLRQRIDQ\VWXG\SURFHGXUHV
 6XEMHFWKDVDGRFXPHQWHGJHQHWLFPXWDWLRQFRQVLVWHQWZLWK(%6
6XEMHFWVZKRSDUWLFLSDWHGLQWKH&&3RUWKH&&3VWXG\DUHHOLJLEOHWREH
UROOHGLQWRWKH&&3RSHQODEHOH[WHQVLRQVWXG\UHJDUGOHVVRIWKHLUFRPSOHWLRQ
VWDWXVRQWKHIHHGHUVWXG\
 6XEMHFWFDUHJLYHUDJUHHVWRUHSRUWXVHRIDQ\WRSLFDOWKHUDSLHVDSSOLHGWR(%6OHVLRQV
HJPHGLFDWHGFOHDQVHUVEOHDFKFOHDQVHUVEOHDFKEDWKVWRSLFDODQWLVHSWLFVWRSLFDO
GLVLQIHFWDQWVHWF
 ,IWKHVXEMHFWLVDZRPDQRIFKLOGEHDULQJSRWHQWLDOVKHKDVDQHJDWLYHXULQHSUHJQDQF\
WHVWDQGDJUHHVWRXVHDQDSSURYHGHIIHFWLYHPHWKRGRIELUWKFRQWURODVGHILQHGE\WKLV
SURWRFROVHH6HFWLRQIRUWKHGXUDWLRQRIWKHVWXG\
 6XEMHFWLVQRQODFWDWLQJDQGLVQRWSODQQLQJIRUSUHJQDQF\GXULQJWKHVWXG\SHULRG
 6XEMHFWLVZLOOLQJDQGDEOHWRIROORZDOOVWXG\LQVWUXFWLRQVDQGWRDWWHQGDOOVWXG\YLVLWV


([FOXVLRQ&ULWHULD
$Q\VXEMHFWZKRPHHWVRQHRUPRUHRIWKHIROORZLQJFULWHULDZLOOQRWEHLQFOXGHGLQWKLVVWXG\
 6XEMHFWKDV(%6OHVLRQVWREHWUHDWHGWKDWDUHLQIHFWHGLH(%6OHVLRQVWKDWUHTXLUH
WRSLFDODQWLELRWLFWKHUDS\WRWUHDWDQLQIHFWLRQ
 6XEMHFWKDVHYLGHQFHRIDV\VWHPLFLQIHFWLRQRUKDVXVHGV\VWHPLFDQWLELRWLFVZLWKLQ
GD\VSULRUWR%DVHOLQH
 7KHVXEMHFWZDVGLVFRQWLQXHGIURPWKHIHHGHUVWXG\GXHWRDQDGYHUVHHYHQWMXGJHGWREH
UHODWHGRUSRVVLEO\UHODWHGWRWKHVWXG\PHGLFDWLRQ
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



 6XEMHFWKDVH[SHULHQFHGDFKDQJHLQFOLQLFDOVWDWXVIURPWKHIHHGHUVWXG\WKDWLQWKH
LQYHVWLJDWRU¶VRSLQLRQSXWVWKHVXEMHFWDWXQGXHULVNWRSDUWLFLSDWH

&RQFRPLWDQWWKHUDSLHV
&RQFRPLWDQWWKHUDSLHVDUHDQ\QHZRUH[LVWLQJRQJRLQJWKHUDS\UHFHLYHGIURP%DVHOLQHXQWLO
GLVFKDUJHIURPWKHVWXG\LQFOXGLQJWKHUDSLHVPRGLILHGIRUQRQPHGLFDOUHDVRQVDQGWKHUDSLHV
XVHGIRUSURSK\OD[LV
&RQFRPLWDQWWKHUDSLHVLQFOXGHGUXJHJSUHVFULSWLRQRYHUWKHFRXQWHU>27&@DQGQRQGUXJ
HJFKLURSUDFWLFSK\VLFDOWKHUDS\HQHUJ\EDVHGWUHDWPHQWV>HJODVHUVOLJKWEDVHGWKHUDS\@
WKHUDSLHV7KHXVHRIDQLQYHVWLJDWRUDSSURYHGEODQGQRQPHGLFDWHGHPROOLHQWPRLVWXUL]HU
PHGLFDWHGFOHDQVHUVEOHDFKEDWKVWRSLFDODQWLVHSWLFVWRSLFDOGLVLQIHFWDQWVHWFPXVWEHUHSRUWHG
DVDFRQFRPLWDQWWKHUDS\LQWKHFDVHUHSRUWIRUPV&5)V
$OOQHZRUPRGLILHGFRQFRPLWDQWWKHUDSLHVXVHGGXULQJWKHVWXG\PXVWEHUHFRUGHG
$Q\QHZRUPRGLILHGFRQFRPLWDQWWKHUDS\PXVWEHFRQVLGHUHGWRGHWHUPLQHLILWLVUHODWHGWRDQ
DGYHUVHHYHQW$($Q$(PXVWEHUHSRUWHGXQOHVVWKHWKHUDS\LVPRGLILHGIRUQRQPHGLFDO
UHDVRQVHJKHDOWKLQVXUDQFHSXUSRVHVRULWLVIRUSURSK\OD[LVHJYDFFLQDWLRQVWRSLFDO
DQHVWKHWLFVXVHGGXULQJEORRGVDPSOLQJ

3URKLELWHGWKHUDSLHV
6XEMHFWVZLOOEHSURKLELWHGIURPWDNLQJDQ\LQYHVWLJDWLRQDOSURGXFWZLWKWKHH[FHSWLRQRI
'LDFHUHLQ2LQWPHQWWKURXJKRXWWKHLUSDUWLFLSDWLRQLQWKHVWXG\

,QIHFWHG/HVLRQV
(%6OHVLRQVWKDWEHFRPHLQIHFWHGLH(%6OHVLRQVWKDWUHTXLUHWKHUDS\WRWUHDWDQLQIHFWLRQ
GXULQJWKHFRXUVHRIWKHVWXG\VKRXOGEHPDQDJHGIROORZLQJWKHLQYHVWLJDWRU¶VURXWLQHSUDFWLFH
DQGDOOFRQFRPLWDQWWKHUDSLHVUHSRUWHGLQWKHH&5)V
1RVWXG\PHGLFDWLRQDSSOLFDWLRQVVKRXOGEHPDGHWRLQIHFWHGOHVLRQV,IDQ\(%6OHVLRQVDUHQRW
WUHDWHGZLWKVWXG\PHGLFDWLRQEHFDXVHWKH\DUHLQIHFWHGWKLVVLWXDWLRQPXVWEHQRWHGDVDQ
DGYHUVHHYHQW

6XEMHFW'LVFRQWLQXDWLRQIURPWKH6WXG\
6XEMHFWVFDUHJLYHUZLOOEHLQIRUPHGWKDWWKHVXEMHFWVDUHIUHHWRZLWKGUDZIURPWKHVWXG\DWDQ\
WLPHDQGIRUDQ\UHDVRQ
7KHLQYHVWLJDWRUPD\UHPRYHDVXEMHFWIURPWKHVWXG\LILQWKHLQYHVWLJDWRU
VRSLQLRQLWLVQRWLQ
WKHEHVWLQWHUHVWRIWKHVXEMHFWWRFRQWLQXHWKHVWXG\
([DPSOHVRIRWKHUUHDVRQVVXEMHFWVPD\EHGLVFRQWLQXHGIURPWKHVWXG\DUH
x $FKDQJHLQFRPSOLDQFHZLWKDQLQFOXVLRQRUH[FOXVLRQFULWHULRQ
x 2FFXUUHQFHRI$(V
x 2FFXUUHQFHRISUHJQDQF\
x 8VHRIDSURKLELWHGWKHUDS\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



x )DLOXUHWRPDLQWDLQWKHUHTXLUHGDSSOLFDWLRQIUHTXHQF\
x 7KHVWXG\LVGLVFRQWLQXHGE\WKHVSRQVRU
,QFDVHRISUHPDWXUHGLVFRQWLQXDWLRQRIVWXG\SDUWLFLSDWLRQHIIRUWVZLOOEHPDGHWRSHUIRUPDOO
ILQDOVWXG\GD\DVVHVVPHQWV7KHGDWHWKHVXEMHFWLVZLWKGUDZQIURPWKHVWXG\DQGWKHUHDVRQIRU
GLVFRQWLQXDWLRQZLOOEHUHFRUGHGRQWKHVXEMHFW¶V&5)V$OOZLWKGUDZQVXEMHFWVZLWKRQJRLQJ
$(VZLOOEHIROORZHGDVDSSURSULDWH
7KHLQYHVWLJDWRUPXVWLPPHGLDWHO\ZLWKLQKRXUVQRWLI\WKH&DVWOH&UHHN3KDUPDFHXWLFDOV
//&DVVLJQHGVWXG\PRQLWRURIDVXEMHFWGLVFRQWLQXDWLRQ
7KHVWXG\PD\EHGLVFRQWLQXHGDWWKHGLVFUHWLRQRI&DVWOH&UHHN3KDUPDFHXWLFDOV//&6RPH
H[DPSOHVRIUHDVRQVIRUGLVFRQWLQXDWLRQDUHWKHRFFXUUHQFHRIWKHIROORZLQJ
x ,QFUHDVHGIUHTXHQF\VHYHULW\RUGXUDWLRQRINQRZQ$(V
x 0HGLFDOUHJXODWRU\RUHWKLFDOUHDVRQVDIIHFWLQJWKHFRQWLQXHGSHUIRUPDQFHRIWKH
VWXG\


6XEMHFW,GHQWLILHU6,
7KHLQYHVWLJDWRURUGHVLJQHHZLOOUHJLVWHUHDFKVXEMHFWLQWKH&52,QF,QWHUDFWLYH5HVSRQVH
7HFKQRORJ\,57V\VWHPDW%DVHOLQHWRREWDLQD6,
7KH6,IRUPDWZLOOEH11111ZKHUHWKHILUVWGLJLWVDUHWKHLQYHVWLJDWLRQDOFHQWHUVLWHQXPEHU
XVLQJOHDGLQJ]HURVDVDSSURSULDWH7KHILQDOGLJLWVDUHWKHVXEMHFWQXPEHU
7KHVXEMHFWZLOOEHLGHQWLILHGXVLQJWKH6,LQDOOVWXG\GRFXPHQWDWLRQIRUWKHGXUDWLRQRIWKH
VWXG\
,QVWUXFWLRQVIRUXVHRIWKH,57V\VWHPZLOOEHSURYLGHGWRHDFKLQYHVWLJDWRUSULRUWRWKHLQLWLDWLRQ
RIVXEMHFWHQUROOPHQWDWKHUKLVFHQWHU


5HSODFHPHQW6XEMHFWV
6XEMHFWHQUROOPHQWZLOOFRQWLQXHXQWLODOOVXEMHFWVZKRSDUWLFLSDWHLQWKH&&3VWXG\
DQGSDUWLFLSDWHLQWKH&&3VWXG\DUHFRQVLGHUHGIRUHQUROOPHQW6XEMHFWVZKRDUH
HQUROOHGLQWKLVVWXG\DQGGRQRWFRPSOHWHWKHVWXG\ZLOOQRWEHUHSODFHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




,19(67,*$7,21$/3/$1
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWIROORZHGE\ZHHNVRIIWUHDWPHQW
ZLWKDPD[LPXPRIWZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRRQH\HDU6XEMHFWVVKRXOGEHDVVHVVHG
DWPLQLPXPHYHU\ZHHNVIRUGLVHDVHDFWLYLW\2QFHDVXEMHFWFRPSOHWHVWZRF\FOHVRIWUHDWPHQW
RUUHDFKHV:HHNWKHVXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWXG\6XEMHFWVPD\QRWVWDUWDQHZ
WUHDWPHQWF\FOHSDVW:HHNIURP%DVHOLQH9LVLWZLWKRXWSULRUVSRQVRUDSSURYDO7KHGXUDWLRQ
RIDVXEMHFW¶VSDUWLFLSDWLRQLQWKHH[WHQVLRQVWXG\PD\EHDVVKRUWDVZHHNVRUDVORQJDV
ZHHNVGHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGXOHIRUHDFKLQGLYLGXDOVXEMHFW

6WXG\)ORZ&KDUW

9LVLWF
%DVHOLQHD
&\FOH6WDUWDF
0LG&\FOHF
(QGRI&\FOHF
6WXG\'D\:HHNDSSUR[LPDWH
'D\
'D\;
'D\;
ZHHNV
'D\;
ZHHNV
,QIRUPHG&RQVHQW$VVHQW
;



6XEMHFWLGHQWLILHU
;



,QFOXVLRQ	H[FOXVLRQ
;



'HPRJUDSKLFV	PHGLFDOKLVWRU\
;



9LWDOVLJQV
;D


;
&OLQLFDOODERUDWRU\VDPSOHV
;D


;
(&*
;D


;
3UHJQDQF\WHVWE
;D
;
;
;
&OLQLFDO$VVHVVPHQW
;D
;
;
;
'LVSHQVHFROOHFWVWXG\PHGLFDWLRQG

;
;
;
6WXG\PHGLFDWLRQDSSOLFDWLRQH
;Æ;Æ
'LVSHQVHEOLVWHUODQFLQJNLW

;
;

&RQFRPLWDQWWKHUDSLHV

;
;
;
$GYHUVHHYHQWVI

;
;
;
D5HVXOWVIURPIHHGHUVWXG\ZLOOEHXVHGDVGDWDSRLQWIRUWKLVH[WHQVLRQVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVV
WKH'D\%DVHOLQHYLVLWLV!'D\VIURPWKH)LQDOYLVLWRIWKHIHHGHUVWXG\'D\%DVHOLQHPD\EHFRQVLGHUHGWKH
&\FOH6WDUW9LVLWLIWKHLQYHVWLJDWRUGHWHUPLQHVWKHVXEMHFWKDVOHVLRQVWKDWUHTXLUHWUHDWPHQW
E:2&%3RQO\
F$OOYLVLWVZLQGRZVDUHGD\VIURPWDUJHWGD\
G,QLWLDOVWXG\PHGLFDWLRQGLVSHQVDWLRQZLOOEHGHSHQGHQWRQOHVLRQDFWLYLW\RILQGLYLGXDOVXEMHFW¶V(%6DQG
VKRXOGRQO\EHGLVSHQVHGLIWKHVXEMHFWPHHWVWUHDWPHQWFULWHULDHJLIWKH,QYHVWLJDWRUGHWHUPLQHVQROHVLRQV
UHTXLUHWUHDWPHQWQRVWXG\PHGLFDWLRQZLOOEHGLVSHQVHG&ROOHFWLRQRIXVHGVWXG\PHGLFDWLRQZLOOEHJLQDWWKH
YLVLWIROORZLQJWKHILUVWGRVHRIVWXG\PHGLFDWLRQGLVSHQVDWLRQ
H6WXG\PHGLFDWLRQDSSOLFDWLRQZLOOEHGHSHQGHQWRQOHVLRQDFWLYLW\RILQGLYLGXDOVXEMHFW¶V(%6(DFKWUHDWPHQW
F\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPHVWXG\PHGLFDWLRQDSSOLFDWLRQVIROORZHGE\
ZHHNVRIIWUHDWPHQW6XEMHFWVZLOOEHUHTXLUHGWRUHFRUGWUHDWPHQWDSSOLFDWLRQDQGOHVLRQDFWLYLW\YLDWKHH'LDU\
I$WHDFKYLVLWWKH,QYHVWLJDWRUVKRXOGH[DPLQHWKHOHVLRQVEHLQJWUHDWHGIRUDQ\DGYHUVHHYHQWVVSHFLILFWR
WUHDWPHQW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6WXG\9LVLWV'HVFULSWLRQDQG3URFHGXUHV
$ZULWWHQVLJQHGLQIRUPHGFRQVHQWIRUP,&)DQGDVVHQWIRUPDVDSSURSULDWHPXVWEHREWDLQHG
IURPHDFKVXEMHFWFDUHJLYHUSULRUWRSHUIRUPLQJDQ\VWXG\UHODWHGSURFHGXUH


'D\%DVHOLQH9LVLW
5HVXOWVIURPIHHGHUVWXG\ZLOOEHXVHGDVGDWDSRLQWIRUWKLVH[WHQVLRQVWXG\DQGQHHGQRWEH
UHSHDWHGXQOHVVWKH'D\%DVHOLQHYLVLWLV!'D\VIURPWKH)LQDOYLVLWRIWKHIHHGHUVWXG\$W
WKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOO
 5HYLHZDQGH[SODLQWKHQDWXUHRIWKHVWXG\WRWKHVXEMHFWFDUHJLYHUREWDLQWKH
VXEMHFW¶VFDUHJLYHU¶VVLJQDWXUHRQWKHDSSURSULDWHDSSURYHG,&)DVVHQWIRUPDV
DSSURSULDWHDQG+HDOWK,QVXUDQFH3RUWDELOLW\DQG$FFRXQWDELOLW\$FW+,3$$
DXWKRUL]DWLRQ86VXEMHFWVRQO\DQGSURYLGHDVLJQHGDQGGDWHGFRS\WRWKH
VXEMHFWFDUHJLYHU
 &RQILUPWKHVXEMHFWPHHWVDOOLQFOXVLRQFULWHULDDQGQRH[FOXVLRQFULWHULRQ
 5HJLVWHUVXEMHFWLQWKH,57V\VWHPWRREWDLQD6XEMHFW,GHQWLILFDWLRQQXPEHU
 &ROOHFWGHPRJUDSKLFDQGPHGLFDOKLVWRU\LQIRUPDWLRQ
 0HDVXUHYLWDOVLJQV
 &ROOHFWEORRGDQGXULQHVDPSOHVIRUFOLQLFDOODERUDWRU\WHVWV
 3HUIRUPDQ(&*
 &ROOHFWXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUHZRPHQRIFKLOGEHDULQJSRWHQWLDO
:2&%3WKHUHVXOWVPXVWEHQHJDWLYHIRUWKHVXEMHFWWREHHQUROOHGLQWKLVVWXG\
 5HYLHZWKHH'LDU\LQVWUXFWLRQV
3HUIRUPD&OLQLFDO$VVHVVPHQW
D )RUVXEMHFWVZLWKOHVLRQVWKDWUHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU
SURFHHGWR&\FOH6WDUW9LVLWDFWLYLWLHV
E )RUVXEMHFWVZLWKOHVLRQVWKDWGRQRWUHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH
,QYHVWLJDWRUZKRDUHQRWLQLWLDWLQJVWXG\PHGLFDWLRQDSSOLFDWLRQV
L ,QVWUXFWWKHVXEMHFWFDUHJLYHUWRFRQWDFWWKHLQYHVWLJDWRULIVKHKHIHHOV
WKHLU(%6KDVZRUVHQHG
LL 6FKHGXOHWKHQH[WVWXG\YLVLWLQZHHNVRUXSRQZRUVHQLQJRIGLVHDVH
1RWHLIVXEMHFWUHWXUQVIRUWKHQH[WYLVLWDQGGRHVQRWPHHWFULWHULD
IRULQLWLDWLQJF\FOHOHVLRQVUHTXLUHWUHDWPHQWWKHVLWHVKRXOGUHSHDW
VWHSE&\FOHVPD\RQO\VWDUWLIVXEMHFWKDVOHVLRQVWKDWUHTXLUH
WUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU


&\FOH6WDUW9LVLW
1RWH'D\%DVHOLQHPD\EHFRQVLGHUHGWKH&\FOH6WDUW9LVLWLIVXEMHFWVKDYHOHVLRQVWKDW
UHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU
)RUVXEMHFWVZLWKOHVLRQVWKDWUHTXLUHWUHDWPHQWZKRDUHLQLWLDWLQJWKHWUHDWPHQWSHULRG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



 'LVSHQVHVWXG\PHGLFDWLRQDVDSSURSULDWH
 5HYLHZWKHVWXG\PHGLFDWLRQDSSOLFDWLRQWHFKQLTXHZLWKWKHVXEMHFWFDUHJLYHU
 3URYLGHD6XEMHFW,QVWUXFWLRQ6KHHW
 'LVSHQVHDEOLVWHUODQFLQJNLWDQGLQVWUXFWLRQVWRWKHVXEMHFWFDUHJLYHULIQHHGHG
 5HSRUWWKHVXEMHFW¶VRQJRLQJFRQFRPLWDQWWKHUDSLHV
 'RFXPHQWWKHVXEMHFW¶VRQJRLQJDGYHUVHHYHQWVDOOHYHQWVFRQWLQXLQJIURPIHHGHUVWXGLHV
DQGDQ\QHZDGYHUVHHYHQWVPXVWEHUHSRUWHG
 5HYLHZWKHVWXG\LQVWUXFWLRQVLQFOXGLQJH'LDU\ZLWKWKHVXEMHFWFDUHJLYHU
 6FKHGXOHWKH0LG&\FOH9LVLWLQZHHNV


0LG&\FOH9LVLW
7KH0LG&\FOHYLVLWVKRXOGEHVFKHGXOHGZHHNVDIWHUWKH&\FOH6WDUW9LVLW$IWHUWKLVYLVLWLV
SHUIRUPHGWKHVXEMHFWZLOOUHPDLQRIIWUHDWPHQWIRUZHHNV
$WWKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOOSHUIRUPWKHIROORZLQJSURFHGXUHV
 3HUIRUPDXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUH:2&%3
 3HUIRUPWKH&OLQLFDO$VVHVVPHQW
 &ROOHFWDOOVWXG\PHGLFDWLRQ
 'LVSHQVHDEOLVWHUODQFLQJNLWDQGLQVWUXFWLRQVWRWKHVXEMHFWFDUHJLYHULIQHHGHG
 4XHU\WKHVXEMHFWFDUHJLYHUDERXWDQ\FKDQJHVLQWKHVXEMHFW¶VFRQFRPLWDQWWKHUDSLHV
VLQFHWKHSUHYLRXVYLVLWDQGUHSRUWFKDQJHVRQWKHDSSURSULDWHIRUP
 4XHU\WKHVXEMHFWFDUHJLYHULQDQRQGLUHFWLYHPDQQHUDERXWDQ\FKDQJHVLQWKHVXEMHFW¶V
KHDOWKVLQFHWKHSUHYLRXVYLVLWDQGUHSRUWDOO$(VRQWKHDSSURSULDWHIRUP
 &RQILUPWKHVXEMHFWFRQWLQXHVWRFRPSO\ZLWKDOOVWXG\UHVWULFWLRQVLVHOLJLEOHWRFRQWLQXH
LQWKHVWXG\DQGKDVIROORZHGDOOVWXG\LQVWUXFWLRQV
 5HYLHZWKHVWXG\LQVWUXFWLRQVLQFOXGLQJH'LDU\ZLWKWKHVXEMHFWFDUHJLYHU
 6FKHGXOHWKH(QGRI&\FOH9LVLWLQZHHNV


(QGRI&\FOH9LVLW
$IWHUWKHVXEMHFWKDVJRQHZHHNVZLWKRXWVWXG\PHGLFDWLRQWKHLQYHVWLJDWRUZLOOUHHYDOXDWH
WKHVXEMHFWDQGWRGHWHUPLQHLIWKHVXEMHFWLVHOLJLEOHWRLQLWLDWHDQRWKHUWUHDWPHQWF\FOH1RWH
VXEMHFWVPD\QRWVWDUWQHZWUHDWPHQWF\FOHSDVWZHHNZLWKRXWSULRUVSRQVRUDSSURYDO
$WWKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOO
 0HDVXUHYLWDOVLJQV
 &ROOHFWEORRGDQGXULQHVDPSOHVIRUFOLQLFDOODERUDWRU\WHVWV
 3HUIRUPDQ(&*
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



 3HUIRUPDXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUH:2&%3
 3HUIRUPD&OLQLFDO$VVHVVPHQW
D )RUVXEMHFWVZLWKOHVLRQVWKDWUHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU
SURFHHGWR&\FOH6WDUW9LVLWDFWLYLWLHV1RWH2QFHDVXEMHFWFRPSOHWHVWZRF\FOHVRI
WUHDWPHQWRUUHDFKHV:HHNWKHVXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWXG\6XEMHFWV
PD\QRWVWDUWDQHZWUHDWPHQWF\FOHSDVW:HHNZLWKRXWSULRUVSRQVRUDSSURYDO
E )RUVXEMHFWVZLWKOHVLRQVWKDWGRQRWUHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH
,QYHVWLJDWRUZKRDUHQRWLQLWLDWLQJVWXG\PHGLFDWLRQDSSOLFDWLRQV
L ,QVWUXFWWKHVXEMHFWFDUHJLYHUWRFRQWDFWWKHLQYHVWLJDWRULIVKHKHIHHOV
WKHLU(%6KDVZRUVHQHG
LL 4XHU\WKHVXEMHFWFDUHJLYHUDERXWDQ\FKDQJHVLQWKHVXEMHFW¶V
FRQFRPLWDQWWKHUDSLHVVLQFHWKHSUHYLRXVYLVLWDQGUHSRUWFKDQJHVRQWKH
DSSURSULDWHIRUP
LLL 4XHU\WKHVXEMHFWFDUHJLYHULQDQRQGLUHFWLYHPDQQHUDERXWDQ\FKDQJHV
LQWKHVXEMHFW¶VKHDOWKVLQFHWKHSUHYLRXVYLVLWDQGUHSRUWDOO$(VRQWKH
DSSURSULDWHIRUP
LY &RQILUPWKHVXEMHFWFRQWLQXHVWRFRPSO\ZLWKDOOVWXG\UHVWULFWLRQVLV
HOLJLEOHWRFRQWLQXHLQWKHVWXG\DQGKDVIROORZHGDOOVWXG\LQVWUXFWLRQV
LQFOXGLQJH'LDU\
Y 6FKHGXOHWKHQH[WVWXG\YLVLWLQZHHNVRUXSRQZRUVHQLQJRIGLVHDVH
1RWHLIVXEMHFWUHWXUQVIRUWKHQH[WYLVLWDQGGRHVQRWPHHWFULWHULD
IRULQLWLDWLQJF\FOHOHVLRQVUHTXLUHWUHDWPHQWWKHVLWHVKRXOGUHSHDW
VWHSE&\FOHVPD\RQO\VWDUWLIVXEMHFWKDVOHVLRQVWKDWUHTXLUHPHQW
WUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU


(%6/HVLRQ,GHQWLILFDWLRQ
)RUWKLVVWXG\DQ(%6OHVLRQLVGHILQHGDVDEOLVWHULHDIOXLGILOOHGWKLQZDOOHGVWUXFWXUHRU
WKHFUXVWDQGRUHURVLRQDULVLQJIURPDSUHYLRXVEOLVWHUDQGWKHLPPHGLDWHO\VXUURXQGLQJLQWHQVH
HU\WKHPD,QYHVWLJDWRUVZLOOXVHFOLQLFDOMXGJPHQWWRGHWHUPLQHLIWKH(%6OHVLRQUHTXLUHV
WUHDWPHQW,QYHVWLJDWRUVDUHHQFRXUDJHGWRDVVHVVWKHRYHUDOOVHYHULW\RIOHVLRQVHJEOLVWHUV
HURVLRQVFUXVWLQJHU\WKHPDDQGRUSLJPHQWDU\FKDQJHVWRGHWHUPLQHZKLFKOHVLRQVUHTXLUH
WUHDWPHQW

6XEMHFW,QVWUXFWLRQV
$QLQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOSURYLGHDVXEMHFWLQVWUXFWLRQVKHHWWRHDFK
VXEMHFWFDUHJLYHUWRKHOSZLWKFRPSOLDQFHWRWKHVWXG\UHTXLUHPHQWV8SGDWHGLQIRUPDWLRQDQG
LQVWUXFWLRQIRUVXEMHFWVZLOOEHSURYLGHGDVQHFHVVDU\
7KURXJKRXWWKHVWXG\WKHVXEMHFWVVKRXOG
x &RQWLQXHWKHLUURXWLQHFRVPHWLFVDQGVNLQFDUHSURGXFWV
x %OHDFKPHGLFDWHGFOHDQVHUVEOHDFKEDWKVWRSLFDODQWLVHSWLFVWRSLFDOGLVLQIHFWDQWV
HWFDUHDOORZHGDQGGHWDLOVRIXVHPXVWEHUHSRUWHGWRWKHVLWH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



x $YRLGH[SRVLQJWKHWUHDWHG(%6OHVLRQVWRH[FHVVLYHQDWXUDORUDUWLILFLDOXOWUDYLROHW
UDGLDWLRQHJVXQOLJKWWDQQLQJEHGVDQGXVHVXQVFUHHQRQWKHOHVLRQVLIH[FHVVLYH
H[SRVXUHFDQQRWEHDYRLGHG
x 2QO\XVHDWXEHRIVWXG\PHGLFDWLRQIRUDPD[LPXPRIGD\VDIWHUGD\VKDV
HODSVHGIURPGDWHRIRSHQLQJDQHZWXEHRIPHGLFDWLRQVKRXOGEHRSHQHG
x $SSO\VWXG\PHGLFDWLRQVWROHVLRQVLGHQWLILHGE\WKH,QYHVWLJDWRUWKDWUHTXLUH
WUHDWPHQW
x $SSO\VWXG\PHGLFDWLRQGDLO\LQWKHHYHQLQJXQWLOOHVLRQVUHVROYHIRUXSWRZHHNV
x $SSO\VWXG\PHGLFDWLRQGDLO\LQWKHHYHQLQJWRDQ\QHZOHVLRQVWKDWDSSHDULQ
EHWZHHQVWXG\YLVLWVXSWR%6$XQWLOOHVLRQVUHVROYHIRUXSWRZHHNV
x )ROORZWKHLQVWUXFWLRQVIRUEOLVWHUODQFLQJPDQDJHPHQWDQGFDUH
x %ULQJWKHVXEMHFWLQVWUXFWLRQVKHHWDQGDOOVWXG\PHGLFDWLRQWXEHVZLWKWKHPWRHDFK
PLGF\FOHYLVLW


(%6/HVLRQ&DUH

%OLVWHUODQFLQJNLW
$QLQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOGLVSHQVHDQRSWLRQDOEOLVWHUODQFLQJNLWVDQG
LQVWUXFWLRQVWRHYHU\VXEMHFWFDUHJLYHUDVDSSURSULDWH7KHVXEMHFWZLOOEHLQVWUXFWHGWRODQFHDOO
(%6OHVLRQVLQFOXGLQJVWXG\PHGLFDWLRQWUHDWHGOHVLRQVDQGWKRVHQRWWUHDWHGZLWKVWXG\
PHGLFDWLRQHJOHVLRQVH[FHHGLQJ%6$ZLWKLQKRXUVRIDSSHDUDQFH
%OLVWHUODQFLQJNLWVDQGZULWWHQLQVWUXFWLRQVIRUXVHRIWKHNLWVZLOOEHSURYLGHGWRHDFK
LQYHVWLJDWLRQDOFHQWHUSULRUWRWKHLQLWLDWLRQRIVXEMHFWHQUROOPHQW


%DQGDJLQJ'UHVVLQJ8VH
%DQGDJLQJRI(%6OHVLRQVLVQRWSURKLELWHGGXULQJWKLVVWXG\6XEMHFWVVKRXOGEHHQFRXUDJHGWR
UHPDLQFRQVLVWHQWZLWKWKHLUEDQGDJLQJURXWLQHKRZHYHUWKLVLVQRWUHTXLUHG%DQGDJLQJVKRXOG
EHUHFRUGHGLQWKHH&5)DVDFRQFRPLWDQWWKHUDS\
1RWH$OOEDQGDJLQJLVSURKLELWHGIRUWKHILUVWKRXUDIWHUVWXG\PHGLFDWLRQDSSOLFDWLRQ


6WXG\'XUDWLRQ
7KHGXUDWLRQRIVWXG\SDUWLFLSDWLRQIRUDVXEMHFWLVDQWLFLSDWHGWREHDPD[LPXPRIZHHNVDQG
GD\VRUWUHDWPHQWF\FOHVZKLFKHYHULVVKRUWHU6XEMHFWVPD\QRWLQLWLDWHDQHZWUHDWPHQW
F\FOHEH\RQG:HHNZLWKRXWSULRUVSRQVRUDSSURYDO
7KHVWXG\HQGGDWHLVWKHGDWHRIWKHODVWVXEMHFW¶VODVWVWXG\YLVLW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6WXG\0HGLFDWLRQV

6WXG\PHGLFDWLRQLGHQWLW\
7KHVWXG\PHGLFDWLRQLVD\HOORZVWHULOHRLQWPHQW7KHVWXG\PHGLFDWLRQPXVWEHVWRUHGLQD
VHFXUHGDUHDZLWKOLPLWHGDFFHVVXQGHUDSSURSULDWHO\FRQWUROOHGDQGPRQLWRUHGVWRUDJH
FRQGLWLRQV



6WXG\0HGLFDWLRQ,QIRUPDWLRQ
6WXG\PHGLFDWLRQQDPH
'LDFHUHLQ&&32LQWPHQW6WHULOH
0DQXIDFWXUHU
7:L3KDUPDFHXWLFDOV,QF7DR\XDQ&LW\7DLZDQ
'LDFHUHLQFRQFHQWUDWLRQ

3KDUPDFHXWLFDO)RUP
2LQWPHQW
6WRUDJH&RQGLWLRQV
)WR)&WR&
'RVHUHJLPHQ

5RXWH
7RSLFDO
)UHTXHQF\
2QFHGDLO\DSSOLFDWLRQWRDOO(%6OHVLRQV
'XUDWLRQRIDGPLQLVWUDWLRQ
2QFHGDLO\DSSOLFDWLRQVIRUDPD[LPXPRIZHHNVLQD
VLQJOHWUHDWPHQWF\FOH


6WXG\PHGLFDWLRQIRUPXODWLRQ



'LDFHUHLQ
&&3
2LQWPHQW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6WXG\PHGLFDWLRQSDFNDJLQJDQGODEHOLQJ
7KHVWXG\PHGLFDWLRQLVD\HOORZFRORUHGVWHULOHRLQWPHQWDQGZLOOEHSDFNDJHGLQDOXPLQXP
WXEHVWKDWHDFKFRQWDLQDPLQLPXPRIJUDPVRIVWXG\PHGLFDWLRQ
$EXONVXSSO\RI'LDFHUHLQ2LQWPHQWVWXG\PHGLFDWLRQZLWKRQHWXEHLQHDFKFDUWRQZLOOEH
SURYLGHGWRHDFKLQYHVWLJDWLRQDOFHQWHU$VXIILFLHQWVXSSO\RIVWXG\PHGLFDWLRQZLOOEHSURYLGHG
WRHDFKVLWHSULRUWRWKHLQLWLDWLRQRIVXEMHFWHQUROOPHQWDQGUHSOHQLVKHGDVQHHGHG
(DFKVWXG\PHGLFDWLRQFDUWRQZLOOEHODEHOHGZLWKDRQHSDUWODEHOWKDWLVFRPSOHWHGZKHQWKH
WXEHLVGLVSHQVHGUHPDLQVDWWDFKHGWRWKHFDUWRQ
7KHFDUWRQODEHOVKRZVDWOHDVWWKHIROORZLQJ
x 3URWRFROQXPEHU
x 7XEHQXPEHU
x 6WXG\PHGLFDWLRQLGHQWLW\
x ,QYHVWLJDWLRQDOGUXJZDUQLQJ
x 6SDFHWRHQWHUWKH6,
(DFKVWXG\PHGLFDWLRQWXEHZLOOEHODEHOHGZLWKDWZRSDUWODEHO%RWKSDUWVRIWKHODEHODUH
FRPSOHWHGZKHQWKHWXEHLVGLVSHQVHGRQHSDUWRIWKHFRPSOHWHGODEHOUHPDLQVDWWDFKHGWRWKH
WXEHWKHRWKHUSDUWWHDURIILVVHSDUDWHGDQGDWWDFKHGWRWKHVXEMHFW¶VGUXJDFFRXQWDELOLW\ORJ
%RWKSDUWVRIWKHFDUWRQODEHOVKRZDWOHDVWWKHIROORZLQJ
x 3URWRFROQXPEHU
x 7XEHQXPEHU
x 6WXG\PHGLFDWLRQLGHQWLW\
x 6WRUDJHFRQGLWLRQV
x ,QVWUXFWLRQVIRUXVH
x 6SRQVRULQIRUPDWLRQ
x ,QYHVWLJDWLRQDOGUXJZDUQLQJ
x 6SDFHWRHQWHUWKH6,
x 6SDFHWRHQWHUWKHGDWHGLVSHQVHG

0HWKRGRIWUHDWPHQWDVVLJQPHQW
$OOVXEMHFWVZLOOEHDVVLJQHGWRUHFHLYH'LDFHUHLQ2LQWPHQW


6XEMHFWWUHDWPHQWDVVLJQPHQW
$WWKHVWXG\YLVLWZKHQDVXEMHFWLQLWLDWHVDWUHDWPHQWF\FOHWKHLQYHVWLJDWRURUGHVLJQHHZLOO
HOHFWURQLFDOO\FRQWDFWWKH,57V\VWHPWRLGHQWLI\WKHWXEHQXPEHUVWREHGLVSHQVHGWRWKH
VXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



,QVWUXFWLRQVIRUXVHRIWKH,57V\VWHPZLOOEHSURYLGHGWRHDFKLQYHVWLJDWRUSULRUWRWKHLQLWLDWLRQ
RIVXEMHFWHQUROOPHQWDWKHUKLVFHQWHU

'LVSHQVLQJVWXG\PHGLFDWLRQ
7KHVWXG\PHGLFDWLRQPXVWEHGLVSHQVHGRQO\WRVWXG\VXEMHFWVRQO\DWLQYHVWLJDWLRQDOFHQWHUV
VSHFLILHGRQWKH)RUP)'$RULWVHTXLYDOHQWDQGRQO\E\DXWKRUL]HGSHUVRQQHODVUHTXLUHG
E\DSSOLFDEOHUHJXODWLRQVDQGJXLGHOLQHV
7KHVXEMHFWFDUHJLYHUPXVWEULQJGLVSHQVHGVWXG\PHGLFDWLRQWXEHVDQGLISRVVLEOHFDUWRQVZLWK
WKHPWRDOOYLVLWV
$WDVWXG\YLVLWZKHQDVXEMHFWLVHOLJLEOHWREHGLVSHQVHGVWXG\PHGLFDWLRQDQGWKHDVVLJQHG
VWXG\PHGLFDWLRQWXEHVKDYHEHHQLGHQWLILHGDQLQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOO
FRPSOHWHWKHODEHOVDQGGLVSHQVHWKHWXEHWRWKHVXEMHFWFDUHJLYHU
$WDOODSSOLFDEOHYLVLWVH[DPLQHWKHWXEHVRIVWXG\PHGLFDWLRQGLVSHQVHGWRWKH
VXEMHFWFDUHJLYHU8QRSHQHGWXEHVSUHYLRXVO\GLVSHQVHGFDQEHUHGLVSHQVHGWRD
VXEMHFWFDUHJLYHU
$WWKHHQGRIDWUHDWPHQWSHULRGDOOVWXG\PHGLFDWLRQWXEHVZLOOEHFROOHFWHGIURPWKH
VXEMHFWFDUHJLYHU
7KHLQYHVWLJDWLRQDOFHQWHUVWDIIVKRXOGPDNHHYHU\HIIRUWWRREWDLQDOOGLVSHQVHGDQGXQXVHG
VWXG\PHGLFDWLRQ7ZRGRFXPHQWHGWHOHSKRQHFRQWDFWVIROORZHGE\DUHJLVWHUHGOHWWHUWRWKH
VXEMHFWFDUHJLYHUDUHDGHTXDWHIROORZXSHIIRUWV,IWKHVHHIIRUWVIDLOWKHUHDVRQIRUWKHIDLOXUH
PXVWEHQRWHGLQWKH&5)$OOXQXVHGDQGXQGLVSHQVHGVWXG\PHGLFDWLRQVKRXOGEHKHOGIRU
LQVSHFWLRQE\WKHPRQLWRU8SRQFRPSOHWLRQRIWKHVWXG\DOOVWXG\PHGLFDWLRQZLOOEHUHWXUQHGWR
&DVWOH&UHHN3KDUPDFHXWLFDOV//&RUDGHVLJQDWHGWKLUGSDUW\E\WKHPRQLWRUXVLQJDWUDFHDEOH
PHWKRG


6WXG\PHGLFDWLRQDSSOLFDWLRQ
7KHVWXG\PHGLFDWLRQLVIRUH[WHUQDOWRSLFDOXVHRQWKHVXEMHFW¶V(%6OHVLRQVRQO\

$WWKHVWXG\YLVLWZKHUHDVXEMHFWLQLWLDWHVWUHDWPHQWIRUWKHILUVWWLPHRQWKHVWXG\DQ
LQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOUHYLHZWKHDSSURSULDWHDSSOLFDWLRQWHFKQLTXHZLWKWKH
VXEMHFWFDUHJLYHU
7RSHUIRUPDVWXG\PHGLFDWLRQDSSOLFDWLRQWKHVXEMHFWFDUHJLYHUVKRXOG
x :DVKKHUKLVKDQGVEHIRUHVWDUWLQJWKHDSSOLFDWLRQ
x $SSO\VXIILFLHQWTXDQWLW\RIWKHDVVLJQHGVWXG\PHGLFDWLRQWRFRYHUDOO(%6OHVLRQV
DQGWRDERXWôLQFKFPRIXQLQYROYHGVNLQVXUURXQGLQJHDFKOHVLRQZLWKDWKLQ
OD\HUDQGJHQWO\UXELWLQ
x $JHQHUDOUXOHWRIROORZLVILQJHUWLSXQLWRIVWXG\PHGLFDWLRQLVVXIILFLHQWWRFRYHU
DSSUR[LPDWHO\%6$SDOPDUPHWKRGPHDVXUHPHQWIRUWKDWSDUWLFXODUVXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



x 1RWFRYHUWKHWUHDWHGDUHDZLWKDQ\W\SHRIEDQGDJHRUGUHVVLQJIRUKRXUDIWHUWKH
DSSOLFDWLRQ
x :DVKKHUKLVKDQGVDIWHUFRPSOHWLQJWKHDSSOLFDWLRQ
(DFKRSHQHGWXEHRIVWXG\PHGLFDWLRQFDQRQO\EHXVHGIRUGD\V$QHZWXEHRIVWXG\
PHGLFDWLRQVKRXOGQRWEHRSHQHGXQWLOWKHILUVWWXEHLVHLWKHUHPSW\RUKDVEHHQRSHQIRU!
GD\V
7KHVXEMHFWFDUHJLYHUZLOOFRQWLQXHRQFHGDLO\DSSOLFDWLRQVWRHYHU\DFWLYHHJQRWKHDOHG(%6
OHVLRQLQWKHHYHQLQJXQWLOWKHOHVLRQVUHVROYHIRUWKHZHHNWUHDWPHQWSHULRG
$WDOOWUHDWPHQWSHULRGYLVLWVDVWDIIPHPEHUZLOOUHYLHZWKHDSSOLFDWLRQWHFKQLTXHZLWKWKH
VXEMHFWVFDUHJLYHUVWRFRQILUPLWLVEHLQJSURSHUO\SHUIRUPHG
1HZ(%6OHVLRQVXSWR%6$WKDWGHYHORSGXULQJDWUHDWPHQWSHULRGDIWHUF\FOHVWDUWEXW
SULRUWRF\FOHHQGVKRXOGEHWUHDWHGRQFHGDLO\ZLWKVWXG\PHGLFDWLRQXQWLOUHVROYHG
(%6OHVLRQVWKDWDUHH[FOXGHGIURPWUHDWPHQWZLWKWKHVWXG\PHGLFDWLRQHJWKRVHH[FHHGLQJ
%6$PD\EHWUHDWHGIROORZLQJVWDQGDUGRIFDUH

'RVHFRPSOLDQFHUHFRUG
(DFKVXEMHFWFDUHJLYHUZLOOUHFRUGWKHVXEMHFW¶VFRPSOLDQFHZLWKWKHVWXG\PHGLFDWLRQ
DSSOLFDWLRQIUHTXHQF\RQDGDLO\EDVLVLQDQH'LDU\6XEMHFWVFDUHJLYHUVZLOODOVREHUHTXLUHGWR
UHSRUWDQ\QHZ(%6OHVLRQVWKDWUHTXLUHWUHDWPHQWWKDWGHYHORSLQEHWZHHQVWXG\YLVLWVXVLQJWKH
H'LDU\6XEMHFWVFDUHJLYHUVZLOOEHUHTXLUHGWRUHSRUWDGKHUHQFHWREOLVWHUODQFLQJ
UHFRPPHQGDWLRQVXVLQJWKHH'LDU\

'RVHPRGLILFDWLRQ
6XEMHFWVFDUHJLYHUVVKRXOGQRWPRGLI\WKHVWXG\PHGLFDWLRQDSSOLFDWLRQSURFHGXUHRUIUHTXHQF\
ZLWKRXWDSSURYDOIURPWKHLQYHVWLJDWRURUGHVLJQHH
,IDQ\VLJQLILFDQWVWXG\PHGLFDWLRQLQWROHUDQFHRUVDIHW\LVVXHRFFXUVWKHLQYHVWLJDWRURUGHVLJQHH
PD\GLUHFWWKHVXEMHFWFDUHJLYHUWRUHGXFHWKHVWXG\PHGLFDWLRQDSSOLFDWLRQIUHTXHQF\DV
GHWHUPLQHGE\WKHLQYHVWLJDWRU
0RGHUDWHWRVHYHUHGLDUUKHDKDVEHHQREVHUYHGLQVRPHSDWLHQWVDGPLQLVWHUHGRUDOGLDFHUHLQIRU
WKHWUHDWPHQWRIRVWHRDUWKULWLV
x 0RGHUDWHGLDUUKHDZDWHU\VWRROVSHUGD\
x 6HYHUHGLDUUKHD!ZDWHU\VWRROVSHUGD\
6WXG\PHGLFDWLRQDSSOLFDWLRQVVKRXOGEHGLVFRQWLQXHGLIWKHVXEMHFWH[SHULHQFHVPRGHUDWHRU
VHYHUHGLDUUKHD
6WXG\PHGLFDWLRQVKRXOGDOVREHGLVFRQWLQXHGLIWKHVXEMHFWH[SHULHQFHVDQ\LQVWDQFHRIGLDUUKHD
ZLWKEOHHGLQJDQGWKHUHLVQRFOHDUPHGLFDOUDWLRQDOHIRUWKHRFFXUUHQFH
7KHGLDUUKHDPXVWEHUHSRUWHGDVDQDGYHUVHHYHQWLQWKH&5)7KHVHVXEMHFWVVKRXOGEH
ZLWKGUDZQIURPWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6WXG\PHGLFDWLRQ0DQDJHPHQW

$FFRXQWDELOLW\
7KHLQYHVWLJDWRURUGHVLJQHHZLOOPDLQWDLQDQDFFXUDWHUHFRUGRIWKHUHFHLSWRIWKHVWXG\
PHGLFDWLRQVDVVKLSSHGE\&DVWOH&UHHN3KDUPDFHXWLFDOV//&RUGHVLJQHHLQFOXGLQJWKHGDWH
UHFHLYHGDQGWKHFRQGLWLRQRIWKHVWXG\PHGLFDWLRQV2QHFRS\RIWKLVUHFHLSWZLOOEHUHWXUQHGWR
&DVWOH&UHHN3KDUPDFHXWLFDOV//&ZKHQWKHFRQWHQWVRIWKHVWXG\PHGLFDWLRQVKLSPHQWKDYH
EHHQYHULILHGDQGRQHFRS\PDLQWDLQHGLQWKHVWXG\ILOH,QDGGLWLRQDQDFFXUDWHVWXG\
PHGLFDWLRQGLVSRVLWLRQUHFRUGZLOOEHNHSWVSHFLI\LQJWKHDPRXQWGLVSHQVHGWRHDFK
VXEMHFWFDUHJLYHUDQGWKHGDWHRIGLVSHQVLQJ7KLVLQYHQWRU\UHFRUGZLOOEHDYDLODEOHIRU
LQVSHFWLRQDWDQ\WLPH$WWKHFRPSOHWLRQRIWKHVWXG\WKHRULJLQDOLQYHQWRU\UHFRUGZLOOEH
DYDLODEOHIRUUHYLHZE\&DVWOH&UHHN3KDUPDFHXWLFDOV//&XSRQUHTXHVW

5HWXUQDQGGLVSRVLWLRQRIVWXG\VXSSOLHV
$WWKHFRPSOHWLRQRIWKHVWXG\DOOXQXVHGVWXG\PHGLFDWLRQZLOOEHUHWXUQHGWR&DVWOH&UHHN
3KDUPDFHXWLFDOV//&RUGHVLJQHHIRUGLVSRVDOSHU&DVWOH&UHHN3KDUPDFHXWLFDOV//&¶VRU
GHVLJQHH¶VZULWWHQLQVWUXFWLRQV


%OLQGLQJ

9HULILFDWLRQRIEOLQGLQJ
7KLVLVDQRSHQODEHOVWXG\WKHVWXG\PHGLFDWLRQLGHQWLW\LVNQRZQWRERWKWKHVXEMHFWDQGWKH
LQYHVWLJDWRU
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




678'<$66(660(176

6DIHW\(YDOXDWLRQV
,QDGGLWLRQWRUHSRUWLQJDGYHUVHHYHQWVWKURXJKRXWWKHVWXG\WKHLQYHVWLJDWRUDGHVLJQDWHGDQG
DSSURSULDWHO\WUDLQHGVWDIIPHPEHURUWKHVXEMHFWFDUHJLYHUZLOOSHUIRUPWKHIROORZLQJVDIHW\
DVVHVVPHQWVDFFRUGLQJWRWKHVFKHGXOHVQRWHGEHORZ

'HPRJUDSKLFV0HGLFDO+LVWRU\
$WWKHWLPHSRLQWVVSHFLILHGLQWKH6WXG\)ORZ&KDUWWKHLQYHVWLJDWRURUGHVLJQHHZLOOLQWHUYLHZ
HDFKVXEMHFWFDUHJLYHUWRREWDLQGHPRJUDSKLFLQIRUPDWLRQLQFOXGLQJGDWHRIELUWKVH[DWELUWK
UDFHDQGHWKQLFLW\
0HGLFDOKLVWRU\LQIRUPDWLRQZLOOEHUHFRUGHGLQFOXGLQJDOOPHGLFDOFRQGLWLRQVDQGGLVHDVHVWDWHV
WKDWDW%DVHOLQH
x $UHRQJRLQJ
x 5HTXLUHFRQFRPLWDQWWKHUDS\
x $UHLQWKHRSLQLRQRIWKHLQYHVWLJDWRUUHOHYDQWWRWKHVXEMHFW¶VVWXG\SDUWLFLSDWLRQ

9LWDO6LJQV
$WWKHWLPHSRLQWVVSHFLILHGLQWKH6WXG\)ORZ&KDUWDTXDOLILHGVWDIIPHPEHUZLOOPHDVXUHHDFK
VXEMHFW¶VYLWDOVLJQV7KHIROORZLQJLWHPVZLOOEHPHDVXUHG
x %RG\WHPSHUDWXUH
x 3XOVHUDWH
x 5HVSLUDWLRQUDWH
x %ORRGSUHVVXUHV\VWROLFDQGGLDVWROLFDIWHUWKHVXEMHFWVLWVTXLHWO\IRUDWOHDVW
PLQXWHV
x +HLJKW
x :HLJKW
7KHYLWDOVLJQVFROOHFWHGIURPWKHIHHGHUVWXGLHVILQDOYLVLWZLOOEHXVHGDVWKH%DVHOLQHGDWDIRU
WKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWKHYLVLWRFFXUVRXWVLGHWKHZLQGRZDOORZHGLQWKH
6WXG\)ORZ&KDUW

&OLQLFDOODERUDWRU\VDPSOLQJ
$WWKHWLPHSRLQWVVSHFLILHGLQWKH6WXG\)ORZ&KDUWDTXDOLILHGVWDIIPHPEHUZLOOFROOHFWEORRG
DQGXULQHVDPSOHVIRUFOLQLFDOODERUDWRU\DQDO\VLV7RSLFDODQHVWKHWLFVPD\EHXVHGGXULQJWKH
EORRGVDPSOHFROOHFWLRQ,IXVHGWKHWRSLFDODQHVWKHWLFVVKRXOGEHUHSRUWHGDVDFRQFRPLWDQW
WKHUDS\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7KHUHVXOWVRIWKHIHHGHUVWXGLHVILQDOYLVLWFOLQLFDOODERUDWRU\VDPSOHVZLOOEHXVHGDVWKH
%DVHOLQHGDWDIRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWKHYLVLWRFFXUVRXWVLGHWKHZLQGRZ
DOORZHGLQWKH6WXG\)ORZ&KDUW
7KHIROORZLQJWHVWVZLOOEHSHUIRUPHG

&KHPLVWU\3DQHO
&RPSOHWH%ORRG&RXQW
$OEXPLQ
+HPDWRFULW
$ONDOLQHSKRVSKDWDVH$/3
+HPRJORELQ
$ODQLQHDPLQRWUDQVIHUDVH$/7
3ODWHOHWFRXQW
$P\ODVH
5HGEORRGFHOOPRUSKRORJ\
$VSDUWDWHDPLQRWUDQVIHUDVH$67 5HGEORRGFHOOFRXQW
%ORRGXUHDQLWURJHQ%81
:KLWHEORRGFHOOFRXQW
%LFDUERQDWH
:KLWHEORRGFHOOGLIIHUHQWLDO
&KORULGH
DQGDEVROXWH
&UHDWLQLQH
%DVRSKLOV
*DPPD*OXWDP\O7UDQVIHUDVH
**7

*OXFRVH
(RVLQRSKLOV
+E$F
/\PSKRF\WHV
/DFWDWHGHK\GURJHQDVH/'+
0RQRF\WHV
/LSDVH
1HXWURSKLOV
3RWDVVLXP

6RGLXP
&RPSOHWH8ULQDO\VLV
7RWDOELOLUXELQ

7RWDOSURWHLQ

8ULFDFLG

7KHUHVXOWVRIWKHFOLQLFDOODERUDWRU\WHVWVZLOOEHUHSRUWHGRQWKHODERUDWRU\¶VVWDQGDUGUHSRUWV
7KHLQYHVWLJDWRURUGHVLJQHHPXVWUHYLHZDOOODERUDWRU\UHSRUWVLQDWLPHO\PDQQHUDQGQRWH1&5
RU&5WRGHILQHWKHFOLQLFDOUHOHYDQFHRIDQ\UHVXOWWKDWLVRXWVLGHWKHQRUPDOUDQJHIRUWKH
ODERUDWRU\7KHLQYHVWLJDWRURUGHVLJQHHPXVWGDWHDQGLQLWLDOHYHU\ODERUDWRU\UHSRUW
7KHLQYHVWLJDWRUPXVWUHSRUWDOOODERUDWRU\UHVXOWVWKDWDUH%27+RXWVLGHWKHQRUPDOUDQJHIRU
WKHODERUDWRU\$1'LQWKHRSLQLRQRIWKHLQYHVWLJDWRU&5DVPHGLFDOKLVWRU\LIIRXQGSULRUWR
WKHILUVWVWXG\PHGLFDWLRQWUHDWPHQWRUDVDQ$(LIIRXQGDIWHUWKHILUVWVWXG\PHGLFDWLRQ
WUHDWPHQWEHJLQV

(OHFWURFDUGLRJUDP(&*0RQLWRULQJ
6LQJOHOHDG(&*VZLOOEHSHUIRUPHGDVRXWOLQHGLQWKH6WXG\)ORZ&KDUWXVLQJVHQVLWLYH
HOHFWURGHVRURWKHUSUHFDXWLRQDU\PHDVXUHHQVXULQJWKHVXEMHFW¶VVNLQLVQRWKDUPHGIURPWKH
SURFHGXUHHJ6RI7RXFK(OHFWURGHV(&*VZLOOEHSHUIRUPHGRQVXEMHFWVLQVXSLQHSRVLWLRQ
$OO(&*WUDFLQJVZLOOEHUHYLHZHGE\WKH6WXG\3K\VLFLDQRUKLVKHUGHVLJQHH$VXEMHFWZLOOEH
ZLWKGUDZQIURPWKHVWXG\E\WKH6WXG\3K\VLFLDQRUKLVKHUGHVLJQHHLILQWKHLUPHGLFDO
MXGJPHQW(&*ILQGLQJVDUHSUHVHQWZKLFKPDNHFRQWLQXHGVWXG\SDUWLFLSDWLRQQRWLQWKH
VXEMHFW¶VEHVWLQWHUHVW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7KH(&*FRUUHVSRQGLQJWRWKHILQDOYLVLWRIWKHIHHGHUVWXGLHVZLOOEHXVHGDVWKH%DVHOLQHGDWD
IRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHG

3UHJQDQF\WHVWV
$WWKHWLPHSRLQWVVSHFLILHGLQWKH6WXG\)ORZ&KDUWDTXDOLILHGVWDIIPHPEHUZLOOSHUIRUPD
XULQHSUHJQDQF\WHVWIRUVXEMHFWVZKRDUH:2&%37KHXULQHSUHJQDQF\WHVWNLWVXVHGPXVWKDYH
DPLQLPXPVHQVLWLYLW\RIP,8+&*P/RIXULQH
6XEMHFWVZKRDUH:2&%3PXVWKDYHDQHJDWLYHSUHJQDQF\WHVWUHVXOWDW%DVHOLQHWREHHQUROOHG
LQWKHVWXG\
,IWKHUHVXOWRIDQ\SRVWVWXG\PHGLFDWLRQDSSOLFDWLRQXULQHSUHJQDQF\WHVWLVSRVLWLYHWKHVXEMHFW
ZLOOEHZLWKGUDZQIURPWKHVWXG\DQGWKHVXEMHFW¶VSUHJQDQF\ZLOOEHGRFXPHQWHGDQGIROORZHG
XQWLOFRPSOHWLRQDQGIRUDWOHDVWZHHNVDIWHUELUWK
7KHSUHJQDQF\WHVWUHVXOWIURPWKHIHHGHUVWXGLHVILQDOYLVLWDVDSSOLFDEOHZLOOEHXVHGDVWKH
%DVHOLQHGDWDIRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWKHYLVLWRFFXUVRXWVLGHWKHZLQGRZ
DOORZHGLQWKH6WXG\)ORZ&KDUW


2WKHU(YDOXDWLRQV

&OLQLFDO$VVHVVPHQW
7KHLQYHVWLJDWRUZLOOGHWHUPLQHLIWKHVXEMHFWKDVDFWLYH(%6OHVLRQVHJ(%6OHVLRQVWKDW
UHTXLUHWUHDWPHQWZLWKWKHVWXG\PHGLFDWLRQDWWKHWLPHSRLQWVVSHFLILHGLQWKH6WXG\)ORZ&KDUW
7KHLQYHVWLJDWRUZLOOEHUHVSRQVLEOHIRUUHFRUGLQJSUHVHQFHRUDEVHQFHRIDFWLYHOHVLRQVDQG
DVVRFLDWHG%6$RIDOODFWLYHOHVLRQVWKDWUHTXLUHWUHDWPHQW7KHLQYHVWLJDWRUZLOOQRWEH
UHTXLUHGWRDVVHVVOHVLRQVHYHULW\

7RWDO9ROXPHRI%ORRG&ROOHFWHG
7KHWRWDOQXPEHURIYHQLSXQFWXUHVDQGWKHWRWDOYROXPHRIEORRGFROOHFWHGGXULQJWKHVWXG\ZLOO
EHOLPLWHGWRWKDWQHHGHGIRUVDIHW\PRQLWRULQJ7KHWRWDOEORRGYROXPHFROOHFWHGIRUHDFKVXEMHFW
IRUWKHHQWLUHVWXG\ZLOOEHFRPSOLDQWZLWK:+2JXLGHOLQHV'XHWR:+2FRPSOLDQFHVDIHW\
ODERUDWRU\WHVWVZLOOEHSULRULWL]HGLIQRWDOOODERUDWRU\VDPSOHVFDQEHFROOHFWHGGXHWRYROXPH



%DVHOLQH
(QGRI&\FOH
$GXOWV
1$VDPSOHXVHGIURPIHHGHU
VWXG\
PO
&KLOGUHQ\HDUV
1$VDPSOHXVHGIURPIHHGHU
VWXG\
PO
LIVDPSOHVQHHGWREHUHFROOHFWHGEHFDXVHYLVLWRFFXUVRXWVLGHDOORZDEOHZLQGRZPORIEORRG
ZLOOEHGUDZQIRU%DVHOLQH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




$'9(56((9(176
$GYHUVHHYHQWVZLOOEHPRQLWRUHGWKURXJKRXWWKHVWXG\DQGLPPHGLDWHO\UHSRUWHGRQWKH
DSSURSULDWH$(&5)


$GYHUVHHYHQWVV
$QDGYHUVHHYHQWLVGHILQHGDVDQ\XQWRZDUGPHGLFDORFFXUUHQFHLQDFOLQLFDOLQYHVWLJDWLRQ
VXEMHFWDGPLQLVWHUHGDSKDUPDFHXWLFDOSURGXFWZKLFKGRHVQRWQHFHVVDULO\KDYHDFDXVDO
UHODWLRQVKLSZLWKWKLVWUHDWPHQW$QDGYHUVHHYHQWFDQWKHUHIRUHEHDQ\XQIDYRUDEOHDQGRU
XQLQWHQGHGVLJQLQFOXGLQJDQDEQRUPDOODERUDWRU\ILQGLQJV\PSWRPRUGLVHDVHWHPSRUDOO\
DVVRFLDWHGZLWKWKHXVHRIDQLQYHVWLJDWLRQDOPHGLFLQDOSURGXFWZKHWKHURUQRWUHODWHGWRWKH
LQYHVWLJDWLRQDOPHGLFLQDOSURGXFW$OODGYHUVHHYHQWVLQFOXGLQJREVHUYHGRUYROXQWHHUHG
SUREOHPVFRPSODLQWVRUV\PSWRPVDUHWREHUHFRUGHGRQWKHDSSURSULDWH&5)
:RUVHQLQJRIDQ\(%6OHVLRQDVVHVVPHQWVKRXOGEHUHSRUWHGDVDQ$(21/<LIWKHXVHRIWKH
VWXG\PHGLFDWLRQLVLQWHUUXSWHGRUGLVFRQWLQXHGRULIWKHUDS\LVUHTXLUHGWRPDQDJHWKHHYHQW$W
HDFKYLVLWWKH,QYHVWLJDWRUVKRXOGH[DPLQHWKHOHVLRQVEHLQJWUHDWHGIRUDQ\DGYHUVHHYHQWV
VSHFLILFWRWUHDWPHQW(YHQWVVKRXOGEHUHFRUGHGRQWKHDSSURSULDWHH&5)
$GYHUVHHYHQWVZKLFKLQFOXGHFOLQLFDOODERUDWRU\WHVWYDULDEOHVZLOOEHPRQLWRUHGDQG
GRFXPHQWHGIURPWKHWLPHWKHVXEMHFWVLJQVDQLQIRUPHGFRQVHQW$1'KDVDQ\VWXG\UHODWHG
SURFHGXUHFRQGXFWHGXQWLOWKHVXEMHFW¶VVWXG\SDUWLFLSDWLRQLVFRPSOHWH25XQWLOGD\VDIWHU
WKHVXEMHFW¶VODVWVWXG\PHGLFDWLRQDSSOLFDWLRQZKLFKHYHULVORQJHU
$GYHUVHHYHQWVWKDWZHUHUHSRUWHGLQWKH&&3RU&&3VWXGLHVDQGDUHRQJRLQJ
DW%DVHOLQHIRUWKLVVWXG\PXVWEHUHSRUWHGIRUWKLVVWXG\
6XEMHFWFDUHJLYHUVVKRXOGEHLQVWUXFWHGWRUHSRUWDQ\DGYHUVHHYHQWWKDWWKH\H[SHULHQFHWRWKH
,QYHVWLJDWRU,QYHVWLJDWRUVVKRXOGPDNHDQDVVHVVPHQWIRUDGYHUVHHYHQWVDWHDFKYLVLWDQGUHFRUG
WKHHYHQWRQWKHDSSURSULDWHDGYHUVHHYHQW&5)
:KHUHYHUSRVVLEOHDVSHFLILFGLVHDVHRUV\QGURPHUDWKHUWKDQLQGLYLGXDODVVRFLDWHGVLJQVDQG
V\PSWRPVVKRXOGEHLGHQWLILHGE\WKH,QYHVWLJDWRUDQGUHFRUGHGRQWKH&5)+RZHYHULIDQ
REVHUYHGRUUHSRUWHGVLJQRUV\PSWRPLVQRWFRQVLGHUHGDFRPSRQHQWRIDVSHFLILFGLVHDVHRU
V\QGURPHE\WKH,QYHVWLJDWRULWVKRXOGEHUHFRUGHGDVDVHSDUDWHDGYHUVHHYHQWRQWKH&5)
$GGLWLRQDOO\WKHFRQGLWLRQWKDWOHGWRDPHGLFDORUVXUJLFDOSURFHGXUHHJVXUJHU\HQGRVFRS\
WRRWKH[WUDFWLRQRUWUDQVIXVLRQVKRXOGEHUHFRUGHGDVDQDGYHUVHHYHQWQRWWKHSURFHGXUH
$Q\PHGLFDOFRQGLWLRQDOUHDG\SUHVHQWDW%DVHOLQHWKDWLVQRWUHSRUWHGDVDQRQJRLQJ$(IURP
WKH&&3RU&&3VWXGLHVVKRXOGQRWEHUHSRUWHGDVDQDGYHUVHHYHQWXQOHVVWKH
PHGLFDOFRQGLWLRQRUVLJQVRUV\PSWRPVZRUVHQVLQVHYHULW\RUVHULRXVQHVVDWDQ\WLPHGXULQJWKH
VWXG\,QWKLVFDVHLWVKRXOGEHUHSRUWHGDVDQDGYHUVHHYHQW
&OLQLFDOO\VLJQLILFDQWDEQRUPDOODERUDWRU\RURWKHUH[DPLQDWLRQHJHOHFWURFDUGLRJUDP
ILQGLQJVWKDWDUHGHWHFWHGGXULQJWKHVWXG\DUHUHSRUWHGDVRQJRLQJ$(VIURPWKH&&3
RU&&3VWXGLHVDW%DVHOLQHVKRXOGEHUHSRUWHGDVDGYHUVHHYHQWV7KH,QYHVWLJDWRUZLOO
H[HUFLVHKLVRUKHUPHGLFDODQGVFLHQWLILFMXGJPHQWLQGHFLGLQJZKHWKHUDQDEQRUPDOODERUDWRU\
ILQGLQJRURWKHUDEQRUPDODVVHVVPHQWLV&5&5DEQRUPDOODERUDWRU\YDOXHVRFFXUULQJGXULQJWKH
FOLQLFDOVWXG\ZLOOEHIROORZHGXQWLOUHSHDWWHVWVUHWXUQWRQRUPDOVWDELOL]HRUDUHQRORQJHU&5
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



$Q\DEQRUPDOWHVWWKDWLVGHWHUPLQHGWREHDQHUURUGRHVQRWUHTXLUHUHSRUWLQJDVDQDGYHUVH
HYHQW


$GYHUVH'UXJ5HDFWLRQ
$OOQR[LRXVDQGXQLQWHQGHGUHVSRQVHVWRDPHGLFLQDOSURGXFWUHODWHGWRDQ\GRVHVKRXOGEH
FRQVLGHUHGDQDGYHUVHGUXJUHDFWLRQ³5HVSRQVHV´WRDPHGLFLQDOSURGXFWPHDQVWKDWDFDXVDO
UHODWLRQVKLSEHWZHHQDPHGLFLQDOSURGXFWDQGDQDGYHUVHHYHQWLVDWOHDVWDUHDVRQDEOHSRVVLELOLW\
LHWKHUHODWLRQVKLSFDQQRWEHUXOHGRXW


8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQ
$Q8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQLVGHILQHGDVDQDGYHUVHUHDFWLRQWKHQDWXUHRUVHYHULW\
RIZKLFKLVQRWFRQVLVWHQWZLWKWKHDSSOLFDEOHSURGXFWLQIRUPDWLRQ


$VVHVVPHQWVRI$GYHUVH(YHQWVE\WKH,QYHVWLJDWRU
7KH,QYHVWLJDWRUZLOODVVHVVWKHVHYHULW\LQWHQVLW\RIHDFKDGYHUVHHYHQWDVPLOGPRGHUDWHRU
VHYHUHDQGZLOODOVRFDWHJRUL]HHDFKDGYHUVHHYHQWDVWRLWVSRWHQWLDOUHODWLRQVKLSWRVWXG\GUXJ
XVLQJWKHFDWHJRULHVRI\HVRUQR

$VVHVVPHQWRI6HYHULW\
0LOG±$QHYHQWWKDWLVHDVLO\WROHUDWHGDQGJHQHUDOO\QRWLQWHUIHULQJZLWKQRUPDOGDLO\DFWLYLWLHV
0RGHUDWH±$QHYHQWWKDWLVVXIILFLHQWO\GLVFRPIRUWLQJWRLQWHUIHUHZLWKQRUPDOGDLO\DFWLYLWLHV
6HYHUH±$QHYHQWWKDWLVLQFDSDFLWDWLQJZLWKLQDELOLW\WRZRUNRUSHUIRUPQRUPDOGDLO\DFWLYLWLHV

&DXVDOLW\$VVHVVPHQW
7KHUHODWLRQVKLSRIDQDGYHUVHHYHQWWRWKHDGPLQLVWUDWLRQRIWKHVWXG\GUXJLVWREHDVVHVVHG
DFFRUGLQJWRWKHIROORZLQJGHILQLWLRQV

$VVRFLDWLRQ
'HILQLWLRQ
1RWUHODWHG
WKHH[LVWHQFHRIDFOHDUDOWHUQDWLYHH[SODQDWLRQHJPHFKDQLFDOEOHHGLQJDWVXUJLFDO
VLWHRUQRQSODXVLELOLW\HJWKHVXEMHFWLVVWUXFNE\DQDXWRPRELOHRUFDQFHU
GHYHORSLQJDIHZGD\VDIWHUGUXJDGPLQLVWUDWLRQ
8QOLNHO\
7KHUHLVQRPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKH$(PD\EHUHODWHGWRVWXG\GUXJXVDJH
RUWKHUHLVDQRWKHUPRUHSUREDEOHPHGLFDOH[SODQDWLRQ
3RVVLEOH
7KHUHLVPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKHUHLVDUHDVRQDEOHSRVVLELOLW\WKDWWKH$(PD\
EHUHODWHGWRVWXG\GUXJXVDJH+RZHYHURWKHUPHGLFDOH[SODQDWLRQVFDQQRWEHH[FOXGHG
DVDSRVVLEOHFDXVH
3UREDEOH
7KHUHLVVWURQJPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKH$(LVUHODWHGWRVWXG\GUXJXVDJH
'HILQLWH
$FOLQLFDOHYHQWLQFOXGLQJODERUDWRU\WHVWDEQRUPDOLW\LIDSSOLFDEOHLQZKLFKWKHUHLVQR
XQFHUWDLQW\LQLWVUHODWLRQVKLSWRWHVWGUXJHJSRVLWLYH5HFKDOOHQJH

Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7KHIROORZLQJIDFWRUVVKRXOGDOVREHFRQVLGHUHG
x 7KHWHPSRUDOVHTXHQFHIURPVWXG\GUXJDGPLQLVWUDWLRQ
 7KHHYHQWVKRXOGRFFXUDIWHUWKHVWXG\GUXJLVJLYHQ7KHOHQJWKRIWLPHIURP
VWXG\GUXJH[SRVXUHWRHYHQWVKRXOGEHHYDOXDWHGLQWKHFOLQLFDOFRQWH[WRIWKH
HYHQW
x 8QGHUO\LQJFRQFRPLWDQWLQWHUFXUUHQWGLVHDVHV
 (DFKUHSRUWVKRXOGEHHYDOXDWHGLQWKHFRQWH[WRIWKHQDWXUDOKLVWRU\DQGFRXUVHRI
WKHGLVHDVHEHLQJWUHDWHGDQGDQ\RWKHUGLVHDVHWKHVXEMHFWPD\KDYH
x &RQFRPLWDQWGUXJ
 7KHRWKHUGUXJVWKHVXEMHFWLVWDNLQJRUWKHWUHDWPHQWWKHVXEMHFWUHFHLYHVVKRXOG
EHH[DPLQHGWRGHWHUPLQHZKHWKHUDQ\RIWKHPPLJKWEHUHFRJQL]HGWRFDXVHWKH
HYHQWLQTXHVWLRQ
x .QRZQUHVSRQVHSDWWHUQIRUWKLVFODVVRIVWXG\GUXJ
 &OLQLFDODQGRUSUHFOLQLFDOGDWDPD\LQGLFDWHZKHWKHUDSDUWLFXODUUHVSRQVHLV
OLNHO\WREHDFODVVHIIHFW
x ([SRVXUHWRSK\VLFDODQGRUPHQWDOVWUHVVHV
 7KHH[SRVXUHWRVWUHVVPLJKWLQGXFHDGYHUVHFKDQJHVLQWKHUHFLSLHQWDQGSURYLGH
DORJLFDODQGEHWWHUH[SODQDWLRQIRUWKHHYHQW
x 7KHSKDUPDFRORJ\DQGSKDUPDFRNLQHWLFVRIWKHVWXG\GUXJ
 7KHNQRZQSKDUPDFRORJLFSURSHUWLHVDEVRUSWLRQGLVWULEXWLRQPHWDEROLVPDQG
H[FUHWLRQRIWKHVWXG\GUXJVKRXOGEHFRQVLGHUHG


$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW
$QDGYHUVHHYHQWRIVSHFLDOLQWHUHVWVHULRXVRUQRQVHULRXVLVRQHRIVFLHQWLILFDQGPHGLFDO
FRQFHUQVSHFLILFWRWKHSURJUDPIRUZKLFKRQJRLQJPRQLWRULQJDQGUDSLGFRPPXQLFDWLRQE\WKH
LQYHVWLJDWRUWRWKHVSRQVRUPD\EHDSSURSULDWH6XVSLFLRQRIVXFKDQHYHQWPLJKWZDUUDQWIXUWKHU
LQYHVWLJDWLRQLQRUGHUWRFKDUDFWHUL]HDQGXQGHUVWDQGLW&HUWDLQ$(VZLOOEHFDWHJRUL]HGDV$(V
RIVSHFLDOLQWHUHVW$(6,VLQWKLVVWXG\ZLOOLQFOXGHWKHIROORZLQJ
x 0RGHUDWHWRVHYHUHGLDUUKHD
x +HSDWLFLQMXU\
x 3DQFUHDWLWLV
x 8UWLFDULDDQJLRHGHPD
x (SLGHUPDOQHFURO\VLV
x 'UXJUHDFWLRQZLWKHRVLQRSKLOLDDQGV\VWHPLFV\PSWRPV'5(66
x 3XUSXUDFXWDQHRXVYDVFXOLWLV
x -DXQGLFH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



$OO$(6,VZLOOEHVXPPDUL]HGDVQDUUDWLYHVLQWKH&OLQLFDO6WXG\5HSRUW


6HULRXV$GYHUVHHYHQWV6$(
$QDGYHUVHHYHQWRUDGYHUVHUHDFWLRQLVFRQVLGHUHGVHULRXVLILQWKHYLHZRIHLWKHUWKH
,QYHVWLJDWRURU6SRQVRULWUHVXOWVLQDQ\RIWKHIROORZLQJRXWFRPHV
x 'HDWK
x $OLIHWKUHDWHQLQJDGYHUVHHYHQW
 127($QDGYHUVHHYHQWRUDGYHUVHUHDFWLRQLVFRQVLGHUHG³OLIHWKUHDWHQLQJ´LILQ
YLHZRIHLWKHUWKH,QYHVWLJDWRURU6SRQVRULWVRFFXUUHQFHSODFHVWKHVXEMHFWDW
LPPHGLDWHULVNRIGHDWK,WGRHVQRWLQFOXGHDQHYHQWWKDWKDGLWRFFXUUHGLQD
PRUHVHYHUHIRUPPLJKWKDYHFDXVHGGHDWK
x 5HTXLUHVKRVSLWDOL]DWLRQRUSURORQJDWLRQRIH[LVWLQJKRVSLWDOL]DWLRQV
 127($Q\KRVSLWDODGPLVVLRQZLWKDWOHDVWRQHRYHUQLJKWVWD\ZLOOEHFRQVLGHUHG
DQLQSDWLHQWKRVSLWDOL]DWLRQ$QHPHUJHQF\URRPYLVLWZLWKRXWKRVSLWDODGPLVVLRQ
ZLOOQRWEHUHFRUGHGDVD6$(XQGHUWKLVFULWHULRQQRUZLOOKRVSLWDOL]DWLRQIRUD
SURFHGXUHVFKHGXOHGRUSODQQHGEHIRUHVLJQLQJRILQIRUPHGFRQVHQW+RZHYHU
XQH[SHFWHGFRPSOLFDWLRQVDQGRUSURORQJDWLRQRIKRVSLWDOL]DWLRQWKDWRFFXUGXULQJ
HOHFWLYHVXUJHU\VKRXOGEHUHFRUGHGDVDGYHUVHHYHQWVDQGDVVHVVHGIRU
VHULRXVQHVV$GPLVVLRQWRWKHKRVSLWDOIRUVRFLDORUVLWXDWLRQDOUHDVRQVLHQR
SODFHWRVWD\OLYHWRRIDUDZD\WRFRPHIRUKRVSLWDOYLVLWVZLOOQRWEHFRQVLGHUHG
LQSDWLHQWKRVSLWDOL]DWLRQV
x $SHUVLVWHQWRUVLJQLILFDQWGLVDELOLW\LQFDSDFLW\RUVXEVWDQWLDOGLVUXSWLRQRIWKHDELOLW\
WRFRQGXFWQRUPDOOLIHIXQFWLRQV
x $FRQJHQLWDODQRPDO\ELUWKGHIHFWRU
x $QLPSRUWDQWPHGLFDOHYHQW
 127(,PSRUWDQWPHGLFDOHYHQWVWKDWPD\QRWUHVXOWLQGHDWKEHOLIHWKUHDWHQLQJ
RUUHTXLUHKRVSLWDOL]DWLRQPD\EHFRQVLGHUHGDQ6$(ZKHQEDVHGXSRQ
DSSURSULDWHPHGLFDOMXGJPHQWWKH\PD\MHRSDUGL]HWKHVXEMHFWDQGPD\UHTXLUH
PHGLFDORUVXUJLFDOLQWHUYHQWLRQWRSUHYHQWRQHRIWKHRXWFRPHVOLVWHGDERYH
([DPSOHVRIVXFKPHGLFDOHYHQWVLQFOXGHDOOHUJLFEURQFKRVSDVPUHTXLULQJ
LQWHQVLYHWUHDWPHQWLQDQHPHUJHQF\URRPRUDWKRPHEORRGG\VFUDVLDVRU
FRQYXOVLRQVWKDWGRQRWUHVXOWLQLQSDWLHQWKRVSLWDOL]DWLRQVRUWKHGHYHORSPHQWRI
GUXJGHSHQGHQF\


6HULRXV$GYHUVH(YHQW$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW5HSRUWLQJ±
3URFHGXUHVIRU,QYHVWLJDWRUV

 ,QLWLDO5HSRUWV
$OO6$(V$(6,UHJDUGOHVVRIFDXVDOLW\RFFXUULQJIURPWKHWLPHRILQIRUPHGFRQVHQWXQWLO
FRPSOHWLRQRIWKHVXEMHFW¶VODVWVWXG\YLVLW25XQWLOGD\VDIWHUWKHVXEMHFW¶VODVWDSSOLFDWLRQRI
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



VWXG\PHGLFDWLRQZKLFKHYHULVORQJHUPXVWEHUHSRUWHGWR&52&OLQLFDO6DIHW\ZLWKLQKRXUV
RIWKHNQRZOHGJHRIWKHRFFXUUHQFHWKLVUHIHUVWRDQ\DGYHUVHHYHQWWKDWPHHWVDQ\RIWKH
DIRUHPHQWLRQHGVHULRXVFULWHULD6$(V$(6,RFFXUULQJDIWHUWKHGD\IROORZXSSHULRG$1'
FRQVLGHUHGUHODWHGWRVWXG\GUXJPXVWDOVREHUHSRUWHGWRWKH6SRQVRU
6$(V$(6,WKDWZHUHUHSRUWHGIURPWKHIHHGHUVWXGLHVDQGDUHRQJRLQJDW%DVHOLQHIRUWKLVVWXG\
PXVWEHUHSRUWHGIRUWKLVVWXG\
7RUHSRUWDQ6$($(6,FRPSOHWHWKH6$($(6,IRUPHOHFWURQLFDOO\LQWKHHOHFWURQLFGDWD
FDSWXUH('&V\VWHPIRUWKHVWXG\:KHQWKHIRUPLVFRPSOHWHG0HGSDFH6DIHW\SHUVRQQHOZLOO
EHQRWLILHGHOHFWURQLFDOO\,IWKHHYHQWPHHWVVHULRXVFULWHULDDQGLWLVQRWSRVVLEOHWRDFFHVVWKH
('&V\VWHPVHQGDQHPDLOWR0HGSDFH6DIHW\DW0HGSDFHVDIHW\QRWLILFDWLRQ#0HGSDFHFRPRU
FDOOWKH0HGSDFH6$($(6,KRWOLQHSKRQHQXPEHUOLVWHGEHORZDQGID[WKHFRPSOHWHGSDSHU
6$($(6,IRUPWR0HGSDFHID[QXPEHUOLVWHGEHORZZLWKLQKRXUVRIDZDUHQHVV:KHQWKH
('&V\VWHPEHFRPHVDYDLODEOHWKH6$($(6,LQIRUPDWLRQPXVWEHHQWHUHGZLWKLQKRXUVRI
WKHV\VWHPEHFRPLQJDYDLODEOH

6DIHW\&RQWDFW,QIRUPDWLRQ0HGSDFH&OLQLFDO6DIHW\
0HGSDFH6$(KRWOLQH±86$
7HOHSKRQH
)D[
HPDLO

 )ROORZXS5HSRUWV
7KH,QYHVWLJDWRUPXVWFRQWLQXHWRIROORZWKHVXEMHFWXQWLOWKH6$($(6,KDVVXEVLGHGRUXQWLO
WKHFRQGLWLRQEHFRPHVFKURQLFLQQDWXUHVWDELOL]HVLQWKHFDVHRISHUVLVWHQWLPSDLUPHQWRUWKH
VXEMHFWGLHV
:LWKLQKRXUVRIUHFHLSWRIIROORZXSLQIRUPDWLRQWKH,QYHVWLJDWRUPXVWXSGDWHWKH6$($(6,
IRUPHOHFWURQLFDOO\LQWKH('&V\VWHPIRUWKHVWXG\DQGVXEPLWDQ\VXSSRUWLQJGRFXPHQWDWLRQ
HJVXEMHFWGLVFKDUJHVXPPDU\DXWRSV\UHSRUWVHWFWR&52&OLQLFDO6DIHW\YLDID[RUHPDLO
,ILWLVQRWSRVVLEOHWRDFFHVVWKH('&V\VWHPUHIHUWRWKHSURFHGXUHVRXWOLQHGDERYHIRULQLWLDO
UHSRUWLQJRI6$(V$(6,
 ([SHGLWHG5HSRUWV
7KH6SRQVRUZLOOUHSRUWDOOUHOHYDQWLQIRUPDWLRQDERXWVXVSHFWHGXQH[SHFWHGVHULRXVDGYHUVH
UHDFWLRQVWKDWDUHIDWDORUOLIHWKUHDWHQLQJDVVRRQDVSRVVLEOHWRWKH)'$DSSOLFDEOHFRPSHWHQW
DXWKRULWLHVLQDOOWKH0HPEHU6WDWHVFRQFHUQHGDQGWRWKH&HQWUDO(WKLFV&RPPLWWHHDQGLQDQ\
FDVHQRODWHUWKDQGD\VDIWHUNQRZOHGJHE\WKH6SRQVRURIVXFKDFDVHDQGWKDWUHOHYDQW
IROORZXSLQIRUPDWLRQZLOOVXEVHTXHQWO\EHFRPPXQLFDWHGZLWKLQDQDGGLWLRQDOGD\V
$OORWKHUVXVSHFWHGXQH[SHFWHGVHULRXVDGYHUVHUHDFWLRQV$(6,ZLOOEHUHSRUWHGWRWKH)'$
DSSOLFDEOHFRPSHWHQWDXWKRULWLHVFRQFHUQHGDQGWRWKH&HQWUDO(WKLFV&RPPLWWHHFRQFHUQHGDV
VRRQDVSRVVLEOHEXWZLWKLQDPD[LPXPRIGD\VRIILUVWNQRZOHGJHE\WKH6SRQVRU
7KH6SRQVRUZLOODOVRLQIRUPDOOLQYHVWLJDWRUVDVUHTXLUHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




35(*1$1&<5(3257,1*
:2&%3LQFOXGHDQ\IHPDOHZKRKDVH[SHULHQFHGPHQDUFKHDQGZKRKDVQRWXQGHUJRQH
VXFFHVVIXOVXUJLFDOVWHULOL]DWLRQHJK\VWHUHFWRP\ELODWHUDOWXEDOOLJDWLRQELODWHUDO
RRSKRUHFWRP\RULVQRWSRVWPHQRSDXVDO3RVWPHQRSDXVDOLVGHILQHGDVPRQWKVZLWKQR
PHQVHVZLWKRXWDQDOWHUQDWLYHPHGLFDOFDXVH:RPHQZKRDUH:2&%3DQGDUHXVLQJDQDFWLYH
PHWKRGRIELUWKFRQWURODUHSUDFWLFLQJDEVWLQHQFHRUZKHUHWKHSDUWQHULVVWHULOHHJ
YDVHFWRP\VKRXOGEHFRQVLGHUHGWREH:2&%3
$OO:2&%3PXVWXVHDQHIIHFWLYHDFWLYHPHWKRGRIELUWKFRQWUROIRUWKHGXUDWLRQRIVWXG\
SDUWLFLSDWLRQLQDPDQQHUVXFKWKDWULVNRIIDLOXUHLVPLQLPL]HG3HULRGLFDQGRUWHPSRUDU\
DEVWLQHQFHVXFKDVGHFODUDWLRQRIDEVWLQHQFHGXULQJVWXG\SDUWLFLSDWLRQRUIHUWLOLW\DZDUHQHVV
EDVHGPHWKRGVWRSUHYHQWSUHJQDQF\LQFOXGLQJEXWQRWOLPLWHGWRV\PSWRWKHUPDODQGRYXODWLRQ
HVWLPDWLRQE\HLWKHUFDOHQGDUGD\RUVDOLYDU\FHUYLFDOVHFUHWLRQVDUHQRWFRQVLGHUHGHIIHFWLYH
PHWKRGVRIELUWKFRQWUROKRZHYHUWUXH>DEVROXWH@VH[XDODEVWLQHQFHLHLQOLQHZLWKWKH
SUHIHUUHGDQGXVXDOOLIHVW\OHRIWKHSDWLHQWPD\EHSHUPLWWHG(IIHFWLYHPHWKRGVRIELUWKFRQWURO
DSSURYHGIRUXVHLQWKLVVWXG\DUH
x ,PSODQWVHJ1RUSODQWV\VWHP
x ,QMHFWDEOHHJ'HSR3URYHUD
x 7UDQVGHUPDOSDWFK
x &RPELQHGRUDOFRQWUDFHSWLYHV
x %DUULHUPHWKRGVFRQGRPVDQGGLDSKUDJPZLWKVSHUPLFLGH±QRWHGRXEOHEDUULHU
PHWKRGLVUHTXLUHGLIQRRWKHUPHWKRGVRIELUWKFRQWURODUHLQXVH
x ,QWUDXWHULQHGHYLFHVHJ3DUD*DUGDQG0LUHQD
3ULRUWRWULDOHQUROOPHQW:2&%3PXVWEHDGYLVHGRIWKHLPSRUWDQFHRIDYRLGLQJSUHJQDQF\
GXULQJWULDOSDUWLFLSDWLRQDQGWKHSRWHQWLDOULVNIDFWRUVIRUDSUHJQDQF\7KHVXEMHFWFDUHJLYHU
PXVWVLJQDQLQIRUPHGFRQVHQWDVVHQWIRUPGRFXPHQWLQJWKLVGLVFXVVLRQ'XULQJWKHWULDODOO
:2&%3ZLOOEHLQVWUXFWHGWRFRQWDFWWKHLQYHVWLJDWRULPPHGLDWHO\LIWKH\VXVSHFWWKH\PLJKWEH
SUHJQDQWHJPLVVHGRUODWHPHQVWUXDOSHULRG
$OOSUHJQDQFLHVRFFXUULQJIURPWKHWLPHRILQIRUPHGFRQVHQWXQWLOFRPSOHWLRQRIWKHVXEMHFW¶V
ODVWVWXG\YLVLW25XQWLOGD\VDIWHUWKHVXEMHFW¶VODVWDSSOLFDWLRQRIVWXG\PHGLFDWLRQ
ZKLFKHYHULVORQJHUPXVWEHUHSRUWHGWR&52&OLQLFDO6DIHW\ZLWKLQKRXUVRINQRZOHGJHRI
WKHSUHJQDQF\&52&OLQLFDO6DIHW\ZLOOWKHQIRUZDUGWKH([SRVXUHLQXWHURIRUPWRWKH
,QYHVWLJDWRUIRUFRPSOHWLRQ
,IDVXEMHFWFDUHJLYHURULQYHVWLJDWRUVXVSHFWVWKDWWKHVXEMHFWPD\EHSUHJQDQWSULRUWRVWXG\
PHGLFDWLRQDGPLQLVWUDWLRQWKHVWXG\PHGLFDWLRQPXVWEHZLWKKHOGXQWLOWKHUHVXOWVRID
SUHJQDQF\WHVWDUHDYDLODEOH,ISUHJQDQF\LVFRQILUPHGWKHVXEMHFWPXVWQRWUHFHLYHVWXG\
PHGLFDWLRQDQGPXVWEHWHUPLQDWHGIURPWKHVWXG\
,IIROORZLQJVWXG\PHGLFDWLRQDGPLQLVWUDWLRQLWLVGHWHUPLQHGWKDWWKHVXEMHFWPD\KDYHEHHQRU
ZDVSUHJQDQWDWWKHWLPHRIVWXG\PHGLFDWLRQH[SRVXUHLQFOXGLQJDWOHDVWGD\VDIWHUVWXG\
PHGLFDWLRQDGPLQLVWUDWLRQWKHVXEMHFWZLOOLPPHGLDWHO\EHZLWKGUDZQIURPWKHVWXG\DQGHDUO\
WHUPLQDWLRQVWXG\SURFHGXUHVZLOOEHSHUIRUPHGXQOHVVFRQWUDLQGLFDWHGE\SUHJQDQF\7KH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



LQYHVWLJDWRUPXVWLPPHGLDWHO\ZLWKLQKRXUVQRWLI\WKH&DVWOH&UHHN3KDUPDFHXWLFDOV//&
0HGLFDO0RQLWRU
3URWRFROUHTXLUHGSURFHGXUHVIRUWULDOGLVFRQWLQXDWLRQDQGIROORZXSPXVWEHSHUIRUPHGRQWKH
VXEMHFWXQOHVVFRQWUDLQGLFDWHGE\SUHJQDQF\2WKHUDSSURSULDWHSUHJQDQF\IROORZXSSURFHGXUHV
VKRXOGEHFRQVLGHUHGLILQGLFDWHG
7KHVXEMHFW¶VSUHJQDQF\VKRXOGEHIROORZHGE\WKH,QYHVWLJDWRUXQWLOFRPSOHWLRQDQGIRUDWOHDVW
ZHHNVDIWHUELUWK,IWKHSUHJQDQF\HQGVIRUDQ\UHDVRQEHIRUHWKHDQWLFLSDWHGGDWHWKH
,QYHVWLJDWRUVKRXOGQRWLI\&52&OLQLFDO6DIHW\$WWKHFRPSOHWLRQRIWKHSUHJQDQF\WKH
,QYHVWLJDWRUZLOOGRFXPHQWWKHRXWFRPHRIWKHSUHJQDQF\,IWKHRXWFRPHRIWKHSUHJQDQF\PHHWV
WKHFULWHULDIRULPPHGLDWHFODVVLILFDWLRQDVDQ6$(LHSRVWSDUWXPFRPSOLFDWLRQVSRQWDQHRXV
DERUWLRQVWLOOELUWKQHRQDWDOGHDWKRUFRQJHQLWDODQRPDO\WKH,QYHVWLJDWRUVKRXOGIROORZWKH
SURFHGXUHVIRUUHSRUWLQJDQ6$(
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




67$7,67,&$/$1$/<6(6

$QDO\VLV3RSXODWLRQV
7KH6DIHW\3RSXODWLRQZLOOFRQVLVWRIDOOVXEMHFWVZKRUHFHLYHDWOHDVWRQHDSSOLFDWLRQRIVWXG\
PHGLFDWLRQ


'DWD$QDO\VLV

0LVVLQJ'DWD+DQGOLQJ0HWKRGV
2QO\WKHREVHUYHGGDWDZLOOEHVXPPDUL]HGIRUHIILFDF\DQGVDIHW\RIWKHVWXG\1RPLVVLQJGDWD
ZLOOEHLPSXWHG


6XEMHFW,QIRUPDWLRQ
$GHWDLOHGGHVFULSWLRQRIVXEMHFWGLVSRVLWLRQZLOOEHSURYLGHG'HVFULSWLYHVXPPDULHVRI
GHPRJUDSKLFDQGEDVHOLQHFKDUDFWHULVWLFVZLOOEHSUHVHQWHGIRUWKH6DIHW\3RSXODWLRQ


$QDO\VLVRI6DIHW\
6DIHW\PHDVXUHVZLOOLQFOXGHWKHIROORZLQJDVVHVVPHQWV
x 'HPRJUDSKLFV0HGLFDO+LVWRU\
x $GYHUVHHYHQWVDQG6$(V
x 9LWDO6LJQV
x &OLQLFDOH[DPLQDWLRQ
x /DERUDWRU\WHVWLQJ
x (&*V
x 8ULQHSUHJQDQF\WHVWV
$GYHUVHHYHQWVDQGPHGLFDOKLVWRULHVZLOOEHFRGHGXVLQJWKHPRVWFXUUHQWYHUVLRQRIWKH0HGLFDO
'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV0HG'5$1HZRUZRUVHQLQJDGYHUVHHYHQWVDIWHUGRVLQJ
RIVWXG\GUXJZLOOEHVXPPDUL]HGE\V\VWHPRUJDQFODVVSUHIHUUHGWHUPDQGWUHDWPHQW/LVWVRI
VXEMHFWVZKRKDYHDQ6$($(6,RUZKRGLVFRQWLQXHIURPWKHVWXG\GXHWRDQDGYHUVHHYHQWZLOO
EHSURYLGHG
6XPPDU\VWDWLVWLFVIRUODERUDWRU\YDOXHVZLOOEHSURYLGHGDWEDVHOLQHSRVWEDVHOLQHYLVLWVDQGIRU
FKDQJHVIURPEDVHOLQHWRSRVWEDVHOLQHE\WUHDWPHQW9LWDOVLJQVDQG(&*SDUDPHWHUVZLOOEH
VXPPDUL]HGVLPLODUO\2FFXUUHQFHRIVLJQLILFDQWODERUDWRU\DEQRUPDOLWLHVZLOOEHVXPPDUL]HGE\
WUHDWPHQW&OLQLFDOH[DPLQDWLRQDQGRWKHUVDIHW\PHDVXUHPHQWVZLOOEHVXPPDUL]HGDQGOLVWHG


,QWHULP$QDO\VLV
1RLQWHULPDQDO\VLVLVSODQQHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




6DPSOH6L]H&DOFXODWLRQ
1RIRUPDOVDPSOHVL]HFDOFXODWLRQZDVSHUIRUPHGIRUWKLVH[WHQVLRQVWXG\
$SSUR[LPDWHO\VXEMHFWVDUHDQWLFLSDWHGWREHHQUROOHGLQWKLVVWXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXEMHFWVWKDWDUHHQUROOHGZLOOGHSHQG
RQWKHILQDOQXPEHURIVXEMHFWVZKRSDUWLFLSDWHLQWKH&&3RUSDUWLFLSDWHLQWKH&&3
VWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




',5(&7$&&(66726285&('$7$'2&80(176

6WXG\0RQLWRULQJ
%HIRUHDQLQYHVWLJDWLRQDOVLWHFDQHQWHUDSDWLHQWLQWRWKHVWXG\DUHSUHVHQWDWLYHRI&DVWOH&UHHN
3KDUPDFHXWLFDOV//&ZLOOYLVLWWKHLQYHVWLJDWLRQDOVWXG\VLWHWR
x 'HWHUPLQHWKHDGHTXDF\RIWKHIDFLOLWLHV
x 'LVFXVVZLWKWKHLQYHVWLJDWRUVDQGRWKHUSHUVRQQHOWKHLUUHVSRQVLELOLWLHVZLWKUHJDUG
WRSURWRFRODGKHUHQFHDQGWKHUHVSRQVLELOLWLHVRI&DVWOH&UHHN3KDUPDFHXWLFDOV//&
RULWVUHSUHVHQWDWLYHV7KLVZLOOEHGRFXPHQWHGLQD&OLQLFDO6WXG\$JUHHPHQW
EHWZHHQ&DVWOH&UHHN3KDUPDFHXWLFDOV//&DQGWKHLQYHVWLJDWRU
'XULQJWKHVWXG\DPRQLWRUIURP&DVWOH&UHHN3KDUPDFHXWLFDOV//&RUUHSUHVHQWDWLYHZLOOKDYH
UHJXODUFRQWDFWVZLWKWKHLQYHVWLJDWLRQDOVLWHIRUWKHIROORZLQJ
x 3URYLGHLQIRUPDWLRQDQGVXSSRUWWRWKHLQYHVWLJDWRUV
x &RQILUPWKDWIDFLOLWLHVUHPDLQDFFHSWDEOH
x &RQILUPWKDWWKHLQYHVWLJDWLRQDOWHDPLVDGKHULQJWRWKHSURWRFROWKDWGDWDLVEHLQJ
DFFXUDWHO\UHFRUGHGLQWKHFDVHUHSRUWIRUPVDQGWKDWLQYHVWLJDWLRQDOSURGXFW
DFFRXQWDELOLW\FKHFNVDUHEHLQJSHUIRUPHG
x 3HUIRUPVRXUFHGDWDYHULILFDWLRQ7KLVLQFOXGHVDFRPSDULVRQRIWKHGDWDLQWKHFDVH
UHSRUWIRUPVZLWKWKHSDWLHQW¶VPHGLFDOUHFRUGVDWWKHKRVSLWDORUSUDFWLFHDQGRWKHU
UHFRUGVUHOHYDQWWRWKHVWXG\7KLVZLOOUHTXLUHDFFHVVWRDOOUHFRUGVIRUHDFKSDWLHQW
HJFOLQLFFKDUWV
x 5HFRUGDQGUHSRUWDQ\SURWRFROGHYLDWLRQVQRWSUHYLRXVO\VHQWWR&DVWOH&UHHN
3KDUPDFHXWLFDOV//&
x &RQILUP$(VDQG6$(V$(6,KDYHEHHQSURSHUO\GRFXPHQWHGRQ&5)VDQGFRQILUP
DQ\6$(V$(6,KDYHEHHQIRUZDUGHGWR&DVWOH&UHHN3KDUPDFHXWLFDOV//&DQG
WKHLUUHSUHVHQWDWLYHVDQGFRQILUPWKRVH6$(V$(6,WKDWPHWFULWHULDIRUUHSRUWLQJ
KDYHEHHQIRUZDUGHGWRWKH,5%(&DVDSSOLFDEOH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




(7+,&6

(WKLFV5HYLHZ
7KHILQDOVWXG\SURWRFROLQFOXGLQJWKHILQDOYHUVLRQRIWKH,QIRUPHG&RQVHQW)RUPPXVWEH
DSSURYHGRUJLYHQDIDYRUDEOHRSLQLRQLQZULWLQJE\DQ,5%RU,(&DVDSSURSULDWH7KH
LQYHVWLJDWRUPXVWVXEPLWZULWWHQDSSURYDOWR&DVWOH&UHHN3KDUPDFHXWLFDOV//&EHIRUHKHRUVKH
FDQHQUROODQ\SDWLHQWVXEMHFWLQWRWKHVWXG\
7KH3ULQFLSDO,QYHVWLJDWRULVUHVSRQVLEOHIRULQIRUPLQJWKH,5%RU,(&RIDQ\DPHQGPHQWWRWKH
SURWRFROLQDFFRUGDQFHZLWKORFDOUHTXLUHPHQWV,QDGGLWLRQWKH,5%RU,(&PXVWDSSURYHDOO
DGYHUWLVLQJXVHGWRUHFUXLWVXEMHFWVIRUWKHVWXG\7KHSURWRFROPXVWEHUHDSSURYHGE\WKH,5%
RU,(&XSRQUHFHLSWRIDPHQGPHQWVDQGDQQXDOO\DVORFDOUHJXODWLRQVUHTXLUH
7KH3ULQFLSDO,QYHVWLJDWRULVDOVRUHVSRQVLEOHIRUSURYLGLQJWKH,5%ZLWKUHSRUWVRIDQ\
UHSRUWDEOHVHULRXVDGYHUVHGUXJUHDFWLRQVIURPDQ\RWKHUVWXG\FRQGXFWHGZLWKWKHLQYHVWLJDWLRQDO
SURGXFW&DVWOH&UHHN3KDUPDFHXWLFDOV//&ZLOOSURYLGHWKLVLQIRUPDWLRQWRWKH3ULQFLSDO
,QYHVWLJDWRU
3URJUHVVUHSRUWVDQGQRWLILFDWLRQVRIVHULRXVDGYHUVHGUXJUHDFWLRQVZLOOEHSURYLGHGWRWKH,5%
RU,(&DFFRUGLQJWRORFDOUHJXODWLRQVDQGJXLGHOLQHV


(WKLFDO&RQGXFWRIWKH6WXG\
7KHVWXG\ZLOOEHSHUIRUPHGLQDFFRUGDQFHZLWKHWKLFDOSULQFLSOHVWKDWKDYHWKHLURULJLQLQWKH
'HFODUDWLRQRI+HOVLQNLDQGDUHFRQVLVWHQWZLWK,&+*RRG&OLQLFDO3UDFWLFHDSSOLFDEOH
UHJXODWRU\UHTXLUHPHQWVDQGWKH&DVWOH&UHHN3KDUPDFHXWLFDO¶VSROLF\RQ%LRHWKLFV

:ULWWHQ,QIRUPHG&RQVHQW$VVHQW
7KHLQYHVWLJDWRUDWHDFKLQYHVWLJDWLRQDOFHQWHUZLOOHQVXUHWKDWZULWWHQLQIRUPHGFRQVHQWIRUPV
WKDWSURYLGHLQIRUPDWLRQDERXWWKHVWXG\ZLOOEHJLYHQWRDGXOWVXEMHFWV)RUFKLOGDGROHVFHQW
VXEMHFWVZULWWHQLQIRUPHGFRQVHQWDQGDVVHQWIRUPVZLOOEHJLYHQWRWKHFDUHJLYHUDQGWRWKH
DSSOLFDEOHVXEMHFWUHVSHFWLYHO\,QIRUPHGFRQVHQWIRUPVZLOOFRQWDLQDOOWKHHOHPHQWVUHTXLUHGE\
WKH,&+(*XLGHOLQHIRU*&3DQGDQ\DGGLWLRQDOHOHPHQWVUHTXLUHGE\ORFDOUHJXODWLRQV7KH
LQIRUPDWLRQSURYLGHGLQWKHLQIRUPHGFRQVHQWZLOOEHLQDODQJXDJHXQGHUVWDQGDEOHWRWKHDGXOW
VXEMHFWVRUFDUHJLYHURIFKLOGDGROHVFHQWVXEMHFWV
7KHLQYHVWLJDWRUZLOOSURYLGHWKHVXEMHFWDQGRUFDUHJLYHUVXIILFLHQWWLPHWRFRQVLGHUZKHWKHUWR
SDUWLFLSDWHLQWKHWULDO7KHLQYHVWLJDWRUZLOOH[SODLQWRWKHVXEMHFWFDUHJLYHUWKDWWULDO
SDUWLFLSDWLRQLVYROXQWDU\DQGZLWKGUDZDOIURPWKHVWXG\LVDOORZHGDWDQ\WLPHDQGZLWKGUDZDO
ZLOOQRWDGYHUVHO\DIIHFWWKHVXEMHFW¶VPHGLFDOFDUH
$WWKHILUVWVWXG\YLVLWSULRUWRWKHLQLWLDWLRQRIDQ\VWXG\UHODWHGSURFHGXUHVVXEMHFWVFDUHJLYHUV
ZLOOEHDVNHGWRJLYHZULWWHQLQIRUPHGFRQVHQWDQGFKLOGDGROHVFHQWVXEMHFWVZLOOEHDVNHGWR
JLYHDVVHQWDIWHUKDYLQJEHHQLQIRUPHGRIWKHQDWXUHRIWKHVWXG\VWXG\SURFHGXUHVDQG
UHVWULFWLRQVDQGULVNVDQGEHQHILWV7KHLQIRUPHGFRQVHQWDQGDVVHQWGRFXPHQWVDVDSSOLFDEOH
PXVWEHVLJQHGDQGGDWHGE\WKHVXEMHFWFDUHJLYHUSULRUWRVWXG\SDUWLFLSDWLRQ&RSLHVRIWKH
VLJQHGLQIRUPHGFRQVHQWDQGDVVHQWGRFXPHQWVPXVWEHJLYHQWRWKHVXEMHFWFDUHJLYHU
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI



7KH86)'$GRHVQRWGHILQHWKHUHTXLUHGHOHPHQWVRIDQDVVHQWKRZHYHUWKH\PXVWEHDFFXUDWH
QRWEHFRHUFLYHDQGPXVWLQFRUSRUDWHDJHDSSURSULDWHZRUGLQJ3DUHQWVJXDUGLDQVFDUHJLYHUV
PXVWEHJLYHQDQ,5%(&DSSURYHG,&)WRUHYLHZVLJQDQGGDWH/RFDO,5%(&UHTXLUHPHQWV
VXUURXQGLQJDVVHQWVKRXOGEHIROORZHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




'$7$+$1'/,1*$1'5(&25'.((3,1*

(OHFWURQLF&DVH5HSRUW)RUPV
$GHTXDWHDQGDFFXUDWHFDVHUHFRUGVZLOOEHPDLQWDLQHGDQGDOOUHOHYDQWREVHUYDWLRQVDQGGDWD
UHODWHGWRWKHVWXG\ZLOOEHUHFRUGHG
(OHFWURQLF&5)VDQGVXEMHFWGLDULHVZLOOEHXVHGLQWKLVVWXG\7KH&5)ZLOOEHHOHFWURQLFDOO\
VLJQHGDQGGDWHGE\WKH3ULQFLSDO,QYHVWLJDWRURUKLVGHVLJQHHDIWHUKLVKHUUHYLHZ$IWHUWKH
FRPSOHWLRQRIWKHVWXG\FRPSOHWHG&5)VZLOOEHUHWDLQHGLQWKHDUFKLYHV
&RPSOHWHG&5)VZLOOEHUHYLHZHGE\WKHVWXG\PRQLWRULQWKHHOHFWURQLFGDWDFDSWXUHV\VWHP
DJDLQVWWKHVRXUFHGRFXPHQWDWLRQIRUDFFXUDF\DQGFRPSOHWHQHVV

,QVSHFWLRQRI5HFRUGV
&DVWOH&UHHN3KDUPDFHXWLFDOV//&ZLOOEHDOORZHGWRFRQGXFWVLWHYLVLWVWRWKHLQYHVWLJDWLRQ
IDFLOLWLHVIRUWKHSXUSRVHRIPRQLWRULQJDQ\DVSHFWRIWKHVWXG\7KH,QYHVWLJDWRUDJUHHVWRDOORZ
WKHPRQLWRUWRLQVSHFWWKHGUXJVWRUDJHDUHDVWXG\GUXJVWRFNVGUXJDFFRXQWDELOLW\UHFRUGV
VXEMHFWFKDUWVDQGVWXG\VRXUFHGRFXPHQWVDQGRWKHUUHFRUGVUHODWLYHWRVWXG\FRQGXFW

5HWHQWLRQRI5HFRUGV
7KH3ULQFLSDO,QYHVWLJDWRUPXVWPDLQWDLQDOOGRFXPHQWDWLRQUHODWLQJWRWKHVWXG\IRUDSHULRGRI
\HDUVDIWHUWKHODVWPDUNHWLQJDSSOLFDWLRQDSSURYDORULIQRWDSSURYHG\HDUVIROORZLQJWKH
GLVFRQWLQXDQFHRIWKHWHVWDUWLFOHIRULQYHVWLJDWLRQ,ILWEHFRPHVQHFHVVDU\IRU&DVWOH&UHHN
3KDUPDFHXWLFDOV//&RUWKH5HJXODWRU\$XWKRULW\WRUHYLHZDQ\GRFXPHQWDWLRQUHODWLQJWRWKH
VWXG\WKH,QYHVWLJDWRUPXVWSHUPLWDFFHVVWRVXFKUHFRUGV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




38%/,&$7,2132/,&<
7KHLQYHVWLJDWRULVREOLJHGWRSURYLGHWKHVSRQVRUZLWKFRPSOHWHWHVWUHVXOWVDQGDOOGDWDGHULYHG
E\WKHLQYHVWLJDWRUIURPWKHVWXG\'XULQJWKHVWXG\RQO\WKH6SRQVRUPD\PDNHVWXG\
LQIRUPDWLRQDYDLODEOHWRRWKHUVWXG\LQYHVWLJDWRUVRUWRUHJXODWRU\DJHQFLHVH[FHSWDVUHTXLUHGE\
ODZRUUHJXODWLRQ([FHSWDVRWKHUZLVHDOORZDEOHLQWKHFOLQLFDOVWXG\VLWHDJUHHPHQWDQ\SXEOLF
GLVFORVXUHLQFOXGLQJSXEOLFO\DFFHVVLEOHZHEVLWHVUHODWHGWRWKHSURWRFRORUVWXG\UHVXOWVRWKHU
WKDQVWXG\UHFUXLWPHQWPDWHULDOVDQGRUDGYHUWLVHPHQWVLVWKHVROHUHVSRQVLELOLW\RIWKH6SRQVRU
7KH6SRQVRUPD\SXEOLVKDQ\GDWDDQGLQIRUPDWLRQIURPWKHVWXG\LQFOXGLQJGDWDDQG
LQIRUPDWLRQJHQHUDWHGE\WKHLQYHVWLJDWRUZLWKRXWWKHFRQVHQWRIWKHLQYHVWLJDWRU0DQXVFULSW
DXWKRUVKLSIRUDQ\SHHUUHYLHZHGSXEOLFDWLRQZLOODSSURSULDWHO\UHIOHFWFRQWULEXWLRQVWRWKH
SURGXFWLRQDQGUHYLHZRIWKHGRFXPHQW$OOSXEOLFDWLRQVDQGSUHVHQWDWLRQVPXVWEHSUHSDUHGLQ
DFFRUGDQFHZLWKWKLVVHFWLRQDQGWKH&OLQLFDO6WXG\6LWH$JUHHPHQW,QWKHHYHQWRIDQ\
GLVFUHSDQF\EHWZHHQWKHSURWRFRODQGWKH&OLQLFDO6WXG\6LWH$JUHHPHQWWKH&OLQLFDO6WXG\6LWH
$JUHHPHQWZLOOSUHYDLO
,IWKHVWXG\LVEHLQJFRQGXFWHGDVSDUWRIDPXOWLFHQWHUFOLQLFDOVWXG\GDWDIURPDOOVLWHV
SDUWLFLSDWLQJLQWKHVWXG\ZLOOEHSRROHGDQGDQDO\]HGE\WKH6SRQVRURUWKH6SRQVRU¶VGHVLJQHH
7KHILUVWSXEOLFDWLRQRIWKHVWXG\UHVXOWVVKDOOEHPDGHLQFRQMXQFWLRQZLWKWKHUHVXOWVIURPRWKHU
VWXG\VLWHVDVDPXOWLFHQWHUSXEOLFDWLRQ,IDPXOWLFHQWHUSXEOLFDWLRQLVQRWIRUWKFRPLQJZLWKLQ
PRQWKVRIFRPSOHWLRQRIWKHVWXG\DWDOOVLWHVWKHLQYHVWLJDWRUPD\SXEOLVKRUSUHVHQWWKHUHVXOWV
JHQHUDWHGDWKLVRUKHUVLWH
7KHLQYHVWLJDWRUZLOOSURYLGHWKH6SRQVRUZLWKDFRS\RIDQ\SURSRVHGSXEOLFDWLRQRU
SUHVHQWDWLRQIRUUHYLHZDQGFRPPHQWDWOHDVWGD\VSULRUWRVXFKSUHVHQWDWLRQRUVXEPLVVLRQ
IRUSXEOLFDWLRQ7KH6SRQVRUVKDOOLQIRUPWKHLQYHVWLJDWRULQZULWLQJRIDQ\FKDQJHVRUGHOHWLRQV
LQVXFKSUHVHQWDWLRQRUSXEOLFDWLRQUHTXLUHGWRSURWHFWWKH6SRQVRU¶VFRQILGHQWLDODQGSURSULHWDU\
WHFKQLFDOLQIRUPDWLRQDQGWRDGGUHVVLQDFFXUDWHGDWDRULQDSSURSULDWHLQWHUSUHWDWLRQVLQWKH
FRQWH[WRIDQ\SRROHGPXOWLFHQWHUUHVXOWV$WWKHH[SLUDWLRQRIVXFKGD\SHULRGWKH
LQYHVWLJDWRUPD\SURFHHGZLWKWKHSUHVHQWDWLRQRUVXEPLVVLRQIRUSXEOLFDWLRQXQOHVVWKH6SRQVRU
KDVQRWLILHGWKHLQVWLWXWLRQRUWKHLQYHVWLJDWRULQZULWLQJWKDWVXFKSURSRVHGSXEOLFDWLRQRU
SUHVHQWDWLRQGLVFORVHVWKH6SRQVRU¶VFRQILGHQWLDODQGSURSULHWDU\WHFKQLFDOLQIRUPDWLRQ)XUWKHU
XSRQWKHUHTXHVWRIWKH6SRQVRUWKHLQYHVWLJDWRUZLOOGHOD\WKHSXEOLFDWLRQRUSUHVHQWDWLRQIRUDQ
DGGLWLRQDOGD\VWRSHUPLWWKH6SRQVRUWRWDNHQHFHVVDU\DFWLRQVWRSURWHFWLWVLQWHOOHFWXDO
SURSHUW\LQWHUHVWV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI




5()(5(1&(6
 6DODYDVWUX&0HWDO5HFRPPHQGHGVWUDWHJLHVIRUHSLGHUPRO\VLVEXOORVDPDQDJHPHQW
LQ5RPDQLD0DHGLFD%XFKDUS
 +RQ./HWDO$JHDQGHWLRORJ\RIFKLOGKRRGHSLGHUPRO\VLVEXOORVDPRUWDOLW\
-'HUPDWRORJ7UHDWS
 )LQH-'HWDO,QKHULWHGHSLGHUPRO\VLVEXOORVDXSGDWHGUHFRPPHQGDWLRQVRQ
GLDJQRVLVDQGFODVVLILFDWLRQ-$P$FDG'HUPDWROS
 )LQH-(SLGHPLRORJ\RI,QKHULWHG(SLGHUPRO\VLV%XOORVD%DVHGRQ,QFLGHQFH
DQG3UHYDOHQFH(VWLPDWHV)URPWKH1DWLRQDO(SLGHUPRO\VLV%XOORVD5HJLVWU\
-$0$'HUPDWRORJ\S
 1LFRODV3&OLQLFDO3KDUPDFRNLQHWLFVRI'LDFHUHLQ&OLQ3KDUPDFRNLQHW
1RYS
 :DOO\9HWDO'LDFHUHLQIRUWKHWUHDWPHQWRIHSLGHUPRO\VLVEXOORVD²DSKDVH,,
UDQGRPL]HGSODFHERFRQWUROOHGGRXEOHEOLQGPXOWLFHQWHUFOLQLFDOWULDO
3UHVHQWHGDWWKHWK(XURSHDQ$FDGHP\RI'HUPDWRORJ\DQG9HQHURORJ\
&RQJUHVV2FWREHU9LHQQD$XVWULD
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020